Incorporation and Imaging Mixtures
Patent Information
- Application Number
- JP2022580802
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2020-11-16
- Filing Date
- 2021-11-12
- Publication Date
- 2024-11-19
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
Existing sequencing methods struggle to enhance optical signals during nucleotide base calling, as plasmonic nanostructures and dye labels often quench or degrade at inappropriate distances, leading to suboptimal signal detection.
Incorporation of plasmonic nanostructures within sequencing mixtures to precisely position them relative to dye labels, enhancing optical signals through plasmon resonance by maintaining optimal proximity during imaging.
The precise positioning of plasmonic nanostructures with dye labels significantly enhances optical signals, improving detection accuracy and reducing quenching, thereby improving sequencing efficiency.
Smart Images

Figure 00000049_0000 
Figure 00000049_0001 
Figure 00000049_0002
Abstract
Description
[Technical Field]
[0001] CROSS-REFERENCE TO RELATED APPLICATIONS This application claims the benefit of U.S. Provisional Patent Application No. 63 / 114,302, filed November 16, 2020, the contents of which are incorporated herein by reference in their entirety. [Background technology]
[0002] Various protocols in biological or chemical research involve conducting multiple controlled reactions on a localized support surface or within a predetermined reaction chamber. The desired reactions can then be observed or detected, and subsequent analysis can help identify or characterize the chemicals involved in the reactions. In some instances, the controlled reactions change charge, conductivity, or some other electrical property, and thus electronic systems can be used for detection. In other instances, the controlled reactions produce fluorescence, and thus optical systems can be used for detection. Summary of the Invention
[0003] Incorporation and imaging mixtures are disclosed herein. These mixtures are suitable for use in sequencing methods in which nucleotide base calling is performed via detection of optical signals. The mixtures disclosed herein enhance these optical signals through plasmon resonance and precise positioning of plasmonic nanostructures relative to the dye labels of incorporated labeled nucleotides. Several mechanisms and techniques are disclosed herein for localizing the plasmonic nanostructures within the signal, enhancing the proximity of the dye labels that are components of the labeled nucleotides incorporated into nascent nucleic acid strands during sequencing. This localization allows the plasmonic nanostructures to be held within the signal, enhancing the proximity of the dye labels during imaging, and thus the plasmonic nanostructures can enhance the optical signal of the dye labels.
[0004] introduction A first aspect disclosed herein is an incorporation mixture comprising a liquid carrier; a complex comprising a polymerase and a plasmonic nanostructure linked to the polymerase; and a labeled nucleotide, wherein the nucleotide, a 3' OH blocking group attached to the sugar of the nucleotide, and a dye label attached to the base of the nucleotide.
[0005] In an example of the first aspect, the plasmonic nanostructures are selected from the group consisting of gold nanostructures, silver nanostructures, tin nanostructures, rhodium nanostructures, ruthenium nanostructures, palladium nanostructures, osmium nanostructures, iridium nanostructures, platinum nanostructures, chromium nanostructures, copper nanostructures, gallium arsenide nanostructures, doped silicon nanostructures, aluminum nanostructures, magnesium nanostructures, silver and gold composite nanostructures, and combinations thereof.
[0006] In an example of the first aspect, the plasmonic nanostructures are chemically conjugated to amines or cysteines of the polymerase.
[0007] In an example of the first embodiment, an oligonucleotide is bound to a polymerase, and the oligonucleotide hybridizes to a complementary oligonucleotide tether bound to a plasmonic nanostructure.
[0008] In an example of the first embodiment, an oligonucleotide binds to a polymerase, and the oligonucleotide hybridizes to a complementary portion of an oligonucleotide tether that also includes an additional portion wrapped around the plasmonic nanostructure.
[0009] In an example of the first aspect, the plasmonic nanostructure is functionalized with a first member of a binding pair and the polymerase comprises or is functionalized with a second member of the binding pair. In one example, the first and second members comprise a NiNTA ligand and a histidine tag, or streptavidin and biotin, or a spy tag and a spy catcher, or a maleimide and a cysteine, or an azide and a dibenzocyclooctyne.
[0010] It should be understood that any features of the first aspect may be combined together in any desired manner and / or combined with any of the examples disclosed herein to achieve the advantages described in this disclosure, including, for example, enhanced fluorescent signal during sequencing imaging.
[0011] A second aspect disclosed herein is a method comprising: introducing an incorporation mixture into a flow cell containing a cluster of template strands, the incorporation mixture comprising a liquid carrier, a plurality of complexes, each complex comprising a polymerase and a plasmonic nanostructure linked to the polymerase, and a plurality of labeled nucleotides, each labeled nucleotide comprising the nucleotide, a 3'OH blocking group attached to the sugar of the nucleotide, and a dye label attached to the base of the nucleotide, whereby at least one polymerase i) incorporates each one of the labeled nucleotides into a nascent strand along one of the template strands and ii) maintains its linked plasmonic nanostructure within proximity of each one of the labeled nucleotides; and optically imaging the incorporation while the plasmonic nanostructure is maintained.
[0012] It should be understood that any features of the second aspect may be combined together in any desired manner. Furthermore, it should be understood that any combination of features of the first and / or second aspects may be used together and / or combined with any of the examples disclosed herein to achieve the advantages described in this disclosure, including, for example, enhanced fluorescent signal during sequencing imaging.
[0013] A third aspect disclosed herein discloses a kit comprising an incorporation mixture comprising a liquid carrier, a polymerase, and a labeled nucleotide, the labeled nucleotide comprising the nucleotide, a 3'OH blocking group attached to the sugar of the nucleotide, and a dye label attached to the base of the nucleotide, and an imaging mixture comprising a second liquid carrier and a plasmonic nanostructure functionalized to associate itself within proximity of the labeled nucleotide after an incorporation event comprising the labeled nucleotide.
[0014] In an example of the third aspect, the plasmonic nanostructures are selected from the group consisting of gold nanostructures, silver nanostructures, tin nanostructures, rhodium nanostructures, ruthenium nanostructures, palladium nanostructures, osmium nanostructures, iridium nanostructures, platinum nanostructures, chromium nanostructures, copper nanostructures, gallium arsenide nanostructures, doped silicon nanostructures, aluminum nanostructures, magnesium nanostructures, silver and gold composite nanostructures, and combinations thereof.
[0015] In an example of the third aspect, the plasmonic nanostructure is functionalized with a second polymerase. In one example, the plasmonic nanostructure is chemically conjugated to an amine or cysteine of the second polymerase. In another example, an oligonucleotide is bound to the second polymerase, and the oligonucleotide hybridizes to a complementary oligonucleotide tether bound to the plasmonic nanostructure. In yet another example, an oligonucleotide is bound to the second polymerase, and the oligonucleotide hybridizes to a complementary oligonucleotide tether that includes a portion wrapped around the plasmonic nanostructure.
[0016] In an example of the third embodiment, the plasmonic nanostructure is functionalized with a first member of a binding pair, and the polymerase comprises or is functionalized with a second member of the binding pair. In one example, the first and second members comprise a NiNTA ligand and a histidine tag, or streptavidin and biotin, or a spy tag and a spy catcher, or a maleimide and cysteine, or an azide and dibenzocyclooctyne. In some examples, the polymerase further comprises a DNA-binding domain bound to its surface. In other examples, the polymerase further comprises a surface tether bound to its surface and a flow cell surface binding agent bound to the surface tether.
[0017] In an example of the third embodiment, the plasmonic nanostructures are functionalized with streptavidin and the labeled nucleotides are biotinylated.
[0018] It should be understood that any features of the third aspect may be combined together in any desired manner. Furthermore, it should be understood that any combination of features of the first aspect and / or the second aspect and / or the third aspect may be used together and / or combined with any of the examples disclosed herein to achieve the advantages described in this disclosure, including, for example, enhanced fluorescent signal during sequencing imaging.
[0019] A fourth aspect disclosed herein is a method comprising: introducing an incorporation mixture into a flow cell containing a cluster of template strands, the incorporation mixture comprising a liquid carrier, a plurality of polymerases, and a plurality of labeled nucleotides, each labeled nucleotide comprising the nucleotide, a 3'OH blocking group attached to the sugar of the nucleotide, and a dye label attached to the base of the nucleotide, whereby at least one polymerase incorporates a respective one of the labeled nucleotides into a nascent strand along one of the template strands; introducing an imaging mixture into the flow cell, the imaging mixture comprising a second liquid carrier and a plurality of functionalized plasmonic nanostructures, whereby at least one of the functionalized plasmonic nanostructures associates itself within proximity of a respective one of the labeled nucleotides; and optically imaging the incorporation while at least one of the functionalized plasmonic nanostructures is associated with a respective one of the labeled nucleotides.
[0020] In an example of the fourth embodiment, each of the functionalized plasmonic nanostructures is functionalized with a second polymerase, and the method further comprises removing the incorporation mixture prior to introducing the imaging mixture.
[0021] In an example of the fourth embodiment, each of the functionalized plasmonic nanostructures is functionalized with a first member of a binding pair, each of the polymerases comprises a second member of the binding pair, and the method further comprises removing the incorporation mixture prior to introducing the imaging mixture.
[0022] In an example of the fourth embodiment, each of the functionalized plasmonic nanostructures is functionalized with streptavidin and each of the labeled nucleotides is biotinylated, and the method further comprises removing the incorporation mixture prior to introducing the imaging mixture.
[0023] It should be understood that any features of the fourth aspect may be combined together in any desired manner. Furthermore, it should be understood that any combination of features of the first aspect and / or the second aspect and / or the third aspect and / or the fourth aspect may be used together and / or combined with any of the examples disclosed herein to achieve the advantages described in this disclosure, including, for example, enhanced fluorescent signal during sequencing imaging.
[0024] A fifth aspect disclosed herein is a labeled nucleotide comprising a nucleotide, a 3'OH blocking group attached to the sugar of the nucleotide, a dye label attached to the base of the nucleotide, and a plasmonic nanostructure attached to the base of the nucleotide or the dye label.
[0025] In an example of the fifth aspect, the plasmonic nanostructures are selected from the group consisting of gold nanostructures, silver nanostructures, tin nanostructures, rhodium nanostructures, ruthenium nanostructures, palladium nanostructures, osmium nanostructures, iridium nanostructures, platinum nanostructures, chromium nanostructures, copper nanostructures, gallium arsenide nanostructures, doped silicon nanostructures, aluminum nanostructures, magnesium nanostructures, silver and gold composite nanostructures, and combinations thereof.
[0026] In an example of the fifth embodiment, the plasmonic nanostructure is attached to the base of the nucleotide via a double-stranded deoxyribonucleic acid strand.
[0027] In an example of the fifth embodiment, a first linking molecule attaches a dye label to a base of a nucleotide, a second linking molecule attaches a plasmonic nanostructure to the base of the nucleotide, and the first linking molecule has a first length that is within about 3 nm to about 12 nm of a second length of the second linking molecule.
[0028] In an example of the fifth aspect, a first linking molecule attaches a dye label to a base of a nucleotide, a second linking molecule attaches a plasmonic nanostructure to the base of the nucleotide, the first linking molecule has a first length, and the second linking molecule has a second length, and the combined first and second lengths are in the range of about 3 nm to about 12 nm.
[0029] It should be understood that any features of the fifth aspect may be combined together in any desired manner. Furthermore, it should be understood that any combination of features of the first aspect and / or the second aspect and / or the third aspect and / or the fourth aspect and / or the fifth aspect may be used together and / or in combination with any of the examples disclosed herein to achieve the advantages described in this disclosure, including, for example, enhanced fluorescent signal during sequencing imaging.
[0030] A sixth aspect disclosed herein is a method comprising: introducing an incorporation mixture into a flow cell containing a cluster of template strands, the incorporation mixture comprising a liquid carrier, a plurality of polymerases, and a plurality of labeled nucleotides, each labeled nucleotide comprising the nucleotide, a 3'OH blocking group attached to a sugar of the nucleotide, a dye label attached to a base of the nucleotide, and a plasmonic nanostructure attached to the base of the nucleotide, whereby at least one polymerase incorporates individual ones of the labeled nucleotides into nascent strands along one of the template strands; and optically imaging the incorporation.
[0031] It should be understood that any features of the sixth aspect may be combined together in any desired manner. Furthermore, it should be understood that any combination of features of the first aspect and / or the second aspect and / or the third aspect and / or the fourth aspect and / or the fifth aspect and / or the sixth aspect may be used together and / or in combination with any of the examples disclosed herein to achieve the advantages described in this disclosure, including, for example, enhanced fluorescent signal during sequencing imaging. [Brief explanation of the drawings]
[0032] Features of examples of the present disclosure will become apparent by reference to the following detailed description and drawings, in which like reference numbers correspond to similar, but perhaps not identical, components. For purposes of brevity, reference numbers or features having a previously mentioned function may or may not be described in conjunction with other drawings in which they appear. [Figure 1] FIG. 1 is a schematic diagram of an example of an integration mixture. [Figure 2A] FIG. 1 is a schematic diagram of an exemplary plasmonic nanostructure coupled to a polymerase via a hybridized oligonucleotide. [Figure 2B] FIG. 1 is a schematic diagram of an exemplary plasmonic nanostructure attached to a hybridized oligonucleotide and a polymerase via an oligonucleotide tether long enough to wrap around the plasmonic nanostructure. [Figure 3] FIG. 2 is a schematic diagram of an integration event involving the integration mixture of FIG. 1. [Figure 4] FIG. 1 is a schematic diagram showing the chemical structures of different examples of labeled nucleotides. [Figure 5A] FIG. 1 is a schematic diagram of another example of an integration mixture. [Figure 5B] FIG. 1 is a schematic diagram of another example of an integration mixture. [Figure 6] FIG. 5B is a schematic diagram of an integration event comprising the integration mixture of FIG. 5A. [Figure 7A] FIG. 1 is a schematic diagram of an exemplary kit containing different examples of an incorporation mixture and different examples of an imaging mixture. [Figure 7B] FIG. 1 is a schematic diagram of an exemplary kit containing different examples of an incorporation mixture and different examples of an imaging mixture. [Figure 7C] FIG. 1 is a schematic diagram of an exemplary kit containing different examples of an incorporation mixture and different examples of an imaging mixture. [Figure 8A] FIG. 1 is a top view of an example flow cell. [Figure 8B]8B is an enlarged cross-sectional view taken along line 8B-8B of FIG. 8A, showing an example of a flow channel and non-patterned sequencing surface of a flow cell. [Figure 8C] 8C is an enlarged cross-sectional view taken along line 8C-8C of FIG. 8A, showing an example of a flow channel and patterned sequencing surface of a flow cell. DETAILED DESCRIPTION OF THE INVENTION
[0033] In the examples disclosed herein, nucleotide base calling during sequencing is performed via detection of plasmon-enhanced optical signals. Plasmon resonance-mediated signal enhancement is achieved by precise positioning of plasmon nanostructures relative to the dye labels of incorporated labeled nucleotides. Disclosed herein are mechanisms and techniques for localizing plasmon nanostructures within the dye labels, which enhance the proximity of the dye labels that are components of the labeled nucleotides incorporated into nascent nucleic acid strands during sequencing. By "signal-enhancing proximity," we mean that the plasmon nanostructures and dye labels: i) prevent quenching, which can occur if the plasmon nanostructures and dye labels are too close to each other, and ii) increase plasmon enhancement, which can decrease significantly at greater distances. The distance corresponding to the proximity-enhanced signal can range from greater than 0 nm to about 100 nm, but depends on the plasmon nanostructure (e.g., composition, shape, size) and dye label. In some cases, the distance corresponding to the proximity-enhanced signal ranges from about 0.1 nm to about 25 nm, such as from about 1 nm to about 20 nm. In one specific example, the distance corresponding to the proximity-enhancing signal ranges from about 3 nm to about 12 nm. The mechanisms and techniques disclosed herein enable the plasmonic nanostructures to be held within the proximity-enhancing signal of the dye label during imaging, and thus the plasmonic nanostructures can enhance the optical signal of the dye label.
[0034] definition Terms used herein should be understood to have their ordinary meaning in the relevant art unless otherwise specified. Some terms used herein and their meanings are described below.
[0035] The singular forms "a," "an," and "the" include plural referents unless the context clearly dictates otherwise.
[0036] The terms comprising, including, containing, and the various forms of these terms are synonymous and intended to be equally broad.
[0037] Terms such as top, bottom, lower, upper, adjacent, on, etc. are used herein to describe the flow cell and / or various components of the flow cell. It should be understood that these directional terms are not meant to indicate a particular orientation, but are used to designate the relative orientation between components. The use of directional terms should not be construed to limit the examples disclosed herein to any particular orientation.
[0038] The terms first, second, etc. are also not meant to indicate a particular orientation or order, but rather are used to distinguish one component from another.
[0039] "Acrylamide monomer" has the structure
[0040] [ka] or a monomer containing an acrylamide group. An example of a monomer containing an acrylamide group is azidoacetamidopentylacrylamide:
[0041] [ka] and N-isopropylacrylamide:
[0042] [ka] Other acrylamide monomers may also be used.
[0043] As used herein, an "aldehyde" is an organic compound containing a functional group with the structure -CHO, which contains a carbonyl center (i.e., a carbon double-bonded to oxygen) with a carbon atom also bonded to a hydrogen and an R group, such as an alkyl or other side chain. The general structure of an aldehyde is:
[0044] [ka] is.
[0045] As used herein, "alkyl" refers to a straight or branched hydrocarbon chain that is fully saturated (i.e., contains no double or triple bonds). The alkyl group can have 1 to 20 carbon atoms. Exemplary alkyl groups include methyl, ethyl, propyl, isopropyl, butyl, isobutyl, tertiary butyl, pentyl, hexyl, and the like. As an example, the designation "C1-4 alkyl" indicates that there are 1 to 4 carbon atoms in the alkyl chain, i.e., the alkyl chain is selected from the group consisting of methyl, ethyl, propyl, isopropyl, n-butyl, isobutyl, sec-butyl, and t-butyl.
[0046] As used herein, "alkenyl" refers to a straight or branched hydrocarbon chain containing one or more double bonds. Alkenyl groups can have 2 to 20 carbon atoms. Exemplary alkenyl groups include ethenyl, propenyl, butenyl, pentenyl, hexenyl, and the like.
[0047] As used herein, "alkyne" or "alkynyl" refers to a straight or branched hydrocarbon chain containing one or more triple bonds. Alkynyl groups can have 2 to 20 carbon atoms.
[0048] As used herein, "aryl" refers to an aromatic ring or ring system (i.e., two or more fused rings that share two adjacent carbon atoms) containing only carbon in the ring backbone. When aryl is a ring system, all rings in the system are aromatic. Aryl groups can have 6 to 18 carbon atoms. Examples of aryl groups include phenyl, naphthyl, azulenyl, and anthracenyl.
[0049] The "amino" functional group is -NR a R b refers to a group, wherein R a and R b are each, as defined herein, hydrogen (e.g.,
[0050] [ka] and independently selected from C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C3-7 carbocycle, C6-10 aryl, 5-10 membered heteroaryl, and 5-10 membered heterocycle.
[0051] As used herein, the term "attached" refers to the state in which two things are joined, fastened, adhered, connected, or bound to one another, either directly or indirectly. For example, nucleic acids can be bound to polymer hydrogels by covalent or non-covalent bonds. Covalent bonds are characterized by the sharing of electron pairs between atoms. Non-covalent bonds are physical bonds that do not involve the sharing of electron pairs, and can include, for example, hydrogen bonds, ionic bonds, van der Waals forces, hydrophilic interactions, and hydrophobic interactions.
[0052] An "azide" or "azido" functional group refers to an -N3.
[0053] As used herein, "carbocycle" refers to a non-aromatic cyclic ring or ring system containing only carbon atoms in the ring system backbone. When a carbocycle is a ring system, two or more rings can be joined together in a fused, bridged, or spiro-connected manner. Carbocycles can have any degree of saturation, provided that at least one ring in the ring system is not aromatic. Thus, carbocycles include cycloalkyl, cycloalkenyl, and cycloalkynyl. Carbocyclic groups can have 3 to 20 carbon atoms. Examples of carbocyclic rings include cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cyclohexenyl, 2,3-dihydro-indene, bicyclo[2.2.2]octanyl, adamantyl, and spiro[4.4]nonanyl.
[0054] As used herein, the term "carboxylic acid" or "carboxyl" as used herein refers to --COOH.
[0055] The term "complex" refers to a polymerase having a plasmonic nanostructure linked to it.
[0056] As used herein, "cycloalkylene" means a fully saturated carbocyclic ring or ring system attached to the rest of the molecule through two points of attachment.
[0057] As used herein, "cycloalkenyl" or "cycloalkene" means a carbocyclic ring or ring system having at least one double bond, wherein none of the rings in the ring system are aromatic. Examples include cyclohexenyl or cyclohexene and norbornenyl or norbornene. Also used herein, "heterocycloalkenyl" or "heterocycloalkene" means a carbocyclic ring or ring system having at least one double bond and at least one heteroatom in the ring backbone, wherein none of the rings in the ring system are aromatic.
[0058] As used herein, "cycloalkynyl" or "cycloalkyne" means a carbocyclic ring or ring system having at least one triple bond, wherein none of the rings in the ring system are aromatic. An example is cyclooctyne. Another example is biclononyne. As used herein, "heterocycloalkynyl" or "heterocycloalkyne" means a carbocyclic ring or ring system having at least one heteroatom in the ring backbone, wherein the ring has at least one triple bond, wherein none of the rings in the ring system are aromatic.
[0059] As used herein, the term "depression" refers to a discrete depression feature defined in a substrate having a surface opening at least partially surrounded by a void region(s) of the substrate. The depression can take a variety of shapes at the surface opening, such as, for example, a circle, an oval, a square, a polygon, a star (with any number of vertices), etc. The cross section of the depression taken perpendicular to the surface can be curved, square, polygonal, hyperbolic, conical, angular, etc. By way of example, the depression can be a well or two interconnected wells.
[0060] The term "each," when used in reference to a collection of items, is intended to identify each individual item in the set, but does not necessarily refer to every item in the set. Exceptions may occur where express disclosure or context clearly dictates otherwise.
[0061] The term "epoxy" (also referred to as a glycidyl or oxirane group) as used herein means
[0062] [ka] Refers to...
[0063] As used herein, the term "flow cell" is intended to mean a container having a flow channel in which a reaction can occur, an inlet for delivering a reagent(s) to the flow channel, and an outlet for removing a reagent(s) from the flow channel. In some examples, the flow cell accommodates detection of a reaction occurring within the flow cell. For example, the flow cell may include one or more transparent surfaces that allow for optical detection of arrays, optically labeled molecules, and the like.
[0064] As used herein, a "flow channel" or "channel" can be a region defined between two bonded components that can selectively receive a liquid sample. In some examples, a flow channel can be defined between two substrates and thus in fluid communication with each active area of the substrates. In other examples, a flow channel can be defined between a substrate and a lid and thus in fluid communication with the active area of the substrates.
[0065] As used herein, "heteroaryl" refers to an aromatic ring or ring system (i.e., two or more fused rings that share two adjacent atoms) containing one or more heteroatoms, i.e., elements other than carbon, including, but not limited to, nitrogen, oxygen, and sulfur, in the ring backbone. When a heteroaryl is a ring system, all rings in the system are aromatic. Heteroaryl groups can have 5 to 18 ring members.
[0066] As used herein, "heterocycle" refers to a non-aromatic ring or ring system containing at least one heteroatom in the ring backbone. Heterocycles may be joined together in fused, bridged, or spiro-linked configurations. Heterocycles may have any degree of saturation, provided that at least one ring in the ring system is not aromatic. Within the ring system, the heteroatom may be present in either the non-aromatic or aromatic ring. Heterocyclic groups may have 3 to 20 ring members (i.e., the number of atoms forming the ring backbone, including carbon atoms and heteroatoms). In some examples, the heteroatom is O, N, or S.
[0067] As used herein, the term "hydrazine" or "hydrazinyl" refers to the group -NHNH2.
[0068] As used herein, the term "hydrazone" or "hydrazonyl" as used herein means
[0069] [ka] refers to a group, wherein R a and R b are each independently selected from hydrogen, C alkyl, C alkenyl, C alkynyl, C carbocycle, C aryl, 5-10 membered heteroaryl, and 5-10 membered heterocycle, as defined herein.
[0070] As used herein, "hydroxy" or "hydroxyl" refers to an --OH group.
[0071] As used herein, the term "gap region" refers to a region of a substrate that separates, for example, a depression or surrounds a lane. For example, a gap region can separate one depression of an array from another depression of the array. In another example, a gap region can separate one lane of a flow cell from another lane of the flow cell. Depressions and lanes that are separated from one another may be distinct, i.e., lack physical contact with one another. In many examples, the gap region is continuous, but depressions or lanes are distinct, such as in the case of multiple depressions or lanes defined in or on an otherwise continuous surface. The separation provided by the gap region can be partial or complete. The gap region may have a surface material that is different from the surface material of the depression or lane. For example, a depression or lane can have a polymer hydrogel and a primer therein, while the gap region may not contain both a polymer hydrogel and a primer.
[0072] As used herein, "nitrile oxide" refers to an amine or nitrile compound having a structure similar to that of "Ra C≡N + O - " group, wherein R a is defined herein. Examples of preparation of nitrile oxides include in situ generation from aldoximes by treatment with chloramide-T, or by the action of base on imidoyl chloride [RC(Cl)=NOH], or by reaction of hydroxylamine with an aldehyde.
[0073] As used herein, a "nitrone" is R 3 R except that is not hydrogen (H) 1 , R 2 , and R 3 is R as defined herein a and R b can be any of the groups
[0074] [ka] means a group.
[0075] As used herein, a "nucleotide" comprises a nitrogen-containing heterocyclic base, a sugar, and one or more phosphate groups. Nucleotides are the monomeric units of nucleic acid sequences. In RNA, the sugar is ribose, and in DNA, the sugar is deoxyribose, i.e., a sugar lacking the hydroxyl group at the 2' position of the ribose. The nitrogen-containing heterocyclic base (i.e., nucleobase) can be a purine or pyrimidine base. Purine bases include adenine (A) and guanine (G), as well as modified derivatives or analogs thereof. Pyrimidine bases include cytosine (C), thymine (T), and uracil (U), as well as modified derivatives or analogs thereof. The C-1 atom of deoxyribose is linked to the N-1 atom of a pyrimidine or the N-9 atom of a purine. Nucleic acid analogs may have alterations in either the phosphate backbone, sugar, or nucleobase. Examples of nucleic acid analogs include universal base or phosphate-sugar backbone analogs, such as peptide nucleic acids (PNAs). A "labeled nucleotide" is a nucleotide having at least a dye label attached thereto.
[0076] "Plasmonic nanostructure" includes any free-standing structure capable of exhibiting plasmonic resonance.
[0077] The term "polymer hydrogel" refers to a semi-rigid polymer that is permeable to liquids and gases. Polymer hydrogels can swell when liquid (e.g., water) is removed and can shrink when the liquid is removed, for example, by drying. Hydrogels can absorb water, but are not water-soluble.
[0078] As used herein, the term "primer" is defined as a single-stranded nucleic acid sequence (e.g., single-stranded DNA). Some primers, referred to herein as amplification primers, function as initiation points for template amplification and cluster generation. Other primers, referred to herein as sequencing primers, function as initiation points for DNA synthesis. The 5' end of the primer may be modified to allow for coupling reactions with functional groups on the polymer hydrogel. Primers can be any number of bases in length and can contain a variety of non-natural nucleotides. In one example, sequencing primers are short, ranging from 10 to 60 bases, or 20 to 40 bases.
[0079] The phrase "substantially defines a distance" is used to describe components that create a desired separation between the plasmonic nanostructure and the dye label during imaging. As used herein, this phrase means that the listed component(s) create at least 85% of the desired separation between the plasmonic nanostructure and the dye label. The other 15% may include a portion of the labeled nucleotide (e.g., base), air, or fluid that may be present between the plasmonic nanostructure and the dye label. It should be understood that the components are also flexible and can move rapidly in solution. Therefore, the distance between the plasmonic nanostructure and the dye label may change slightly during imaging.
[0080] A "thiol" functional group refers to a -SH group.
[0081] As used herein, the terms "tetrazine" and "tetrazinyl" refer to a six-membered heteroaryl group containing four nitrogen atoms. The tetrazine may be optionally substituted.
[0082] As used herein, "tetrazole" refers to a five-membered heterocyclic group containing four nitrogen atoms. The tetrazole may be optionally substituted.
[0083] Plasmonic nanostructures As described herein, plasmonic nanostructures include any freestanding structures capable of exhibiting plasmonic resonance. Plasmon resonance is a phenomenon in which electrons in a material surface layer are excited by photons of incident light at a specific angle of incidence and then propagate parallel to the material surface. The surface of a plasmonic nanostructure can strongly confine an electromagnetic field through coupling with propagating or localized surface plasmons. This interaction is associated with a large enhancement of the local electric field, which can improve excitation and emission rates and reduce the excited-state lifetime of fluorescent emitters. This can result in an amplified fluorescent signal and improved resistance to photobleaching.
[0084] Any material capable of plasmon resonance, referred to herein as a "plasmonic material," can be used as a plasmonic nanostructure. Some metals (e.g., gold, silver, tin, rhodium, ruthenium, palladium, osmium, iridium, platinum, copper, aluminum, etc.), doped semimetals (e.g., doped silicon), direct bandgap semiconductors (e.g., gallium arsenide), and metal composites are capable of plasmon resonance. Metal composites can contain two or more of the above metals. For example, a two-metal composite contains silver and gold, and a three-metal composite contains silver, gold, and platinum. In any of the examples described herein, the plasmonic nanostructures can be selected from the group consisting of gold nanostructures, silver nanostructures, tin nanostructures, rhodium nanostructures, ruthenium nanostructures, palladium nanostructures, osmium nanostructures, iridium nanostructures, platinum nanostructures, chromium nanostructures, copper nanostructures, gallium arsenide nanostructures, doped silicon nanostructures, aluminum nanostructures, magnesium nanostructures, silver and gold composite nanostructures, and combinations thereof.
[0085] In one example, the plasmonic nanostructures are spherical nanoparticles. In another example, the plasmonic nanostructures are non-spherical nanoparticles, such as cubic, triangular, rod-shaped, cage-like (e.g., non-spherical, hollow particles with a porous shell), etc. In yet another example, the plasmonic nanostructures are irregularly shaped nanoparticles.
[0086] Plasmonic nanostructures can also be solid, hollow, or core-shell structures. Core-shell structures have one material as the core and another material as the shell that at least partially encapsulates the core. In some instances, two different plasmonic materials are used as the core and shell. In other instances, the core is a plasmonic material and the shell is a non-plasmonic material. Some examples of suitable shell materials include metal oxides such as silica, alumina, titania, and tantalum oxide; proteins such as bovine serum albumin; and organic polymers transparent to the wavelengths used during sequencing, such as poly(methyl methacrylate) (PMMA), poly(lactic acid) (PLA), and poly(methyl acrylate) (PMA). The non-plasmonic material does not interfere with the plasmon resonance of the core, and its thickness can be adjusted to help position the core within the signal, increasing the proximity of dye labels. As one example, when the silica shell of a core-shell plasmonic nanostructure is functionalized with a first member of a binding pair capable of binding to a second member of the binding pair bound to, for example, a labeled nucleotide, the thickness of the silica shell and the length of the binding member of the binding pair (including any linker) substantially define the distance between the dye label and the plasmonic nanostructure core. As another example, when the silica shell of a core-shell plasmonic nanostructure is functionalized with a first member of a binding pair capable of binding to a second member of the binding pair bound to, for example, a polymerase, the length of the binding member of the binding pair (including any linking molecule) and the size of the polymerase substantially define the distance between the dye label and the plasmonic nanostructure core.
[0087] The dimensions of a plasmonic nanostructure can vary depending on its shape. In the examples disclosed herein, the largest dimension (e.g., diameter, length, median, etc.) of the plasmonic nanostructure is nanoscale, and thus ranges from about 1 nm to less than 1000 nm. In some examples, the nanostructure is a nanoparticle having a diameter of 1 nm or more, 2 nm, 3 nm, 4 nm, 5 nm, 6 nm, 7 nm, 8 nm, 9 nm, 10 nm, 20 nm, 30 nm, 40 nm, 50 nm, 60 nm, 70 nm, 80 nm, 90 nm, or 100 nm or more.
[0088] Plasmonic enhancement of optical signals is strongly dependent on the distance of the plasmonic nanostructure from the dye label whose signal is enhanced. The mechanisms and techniques disclosed herein allow the plasmonic nanostructure to be kept within signal-enhancing proximity of the dye label during imaging. Each of these mechanisms and techniques is described herein.
[0089] Plasmonic nanostructures in incorporated mixtures The plasmonic nanostructures can be included in an incorporation mixture. In some instances, the plasmonic nanostructures are part of a complex that also includes a polymerase. In these instances, the complex is a mechanism by which the plasmonic nanostructures are held within a signal that enhances the proximity of the dye label. In other instances, the nanostructures are part of a labeled nucleotide. In these instances, the labeled nucleotide is a mechanism by which the plasmonic nanostructures are held within a signal that enhances the proximity of the dye label.
[0090] An example of an incorporation mixture is shown schematically in Figure 1. This exemplary incorporation mixture 10A includes a liquid carrier 12, a complex 14 including a polymerase 16, and a plasmonic nanostructure 18 linked to the polymerase 16, and a labeled nucleotide 20 including a nucleotide 22, a 3'OH blocking group 24 attached to the sugar of the nucleotide 22, and a dye label 26 attached to the base of the nucleotide 22.
[0091] The liquid carrier 12 of the incorporation mixture 10A can be water and / or an ionic salt buffer, such as millimolar to molar citrate saline, sodium chloride, potassium chloride, phosphate buffered saline, and / or other buffers, such as tris(hydroxymethyl)aminomethane (TRIS) or 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES). The liquid carrier 12 can also be Mg 2+ , Mn 2+ , Ca 2+A single catalytic metal or a combination of catalytic metals may be used, and the total concentration may range from about 0.01 mM to about 100 mM.
[0092] Complex 14 includes polymerase 16 and plasmonic nanostructure 18 linked to polymerase 16. The concentration of complex 14 in incorporation mixture 10A can range from about 1 nM to about 10 mM. As another example, the concentration of complex 14 in incorporation mixture 10A can range from about 50 nM to about 100 μM, from about 1 nM to about 50 μM, etc.
[0093] Any polymerase 16 that can accept a labeled nucleotide 22 and successfully incorporate the nucleotide base into the nascent strand along the template strand can be used. Examples of polymerases include family A polymerases such as Bsu Polymerase, Bst Polymerase, Taq Polymerase, and T7 Polymerase; polymerases from families B and B2 such as Phi29 polymerase and other highly processive polymerases (family B2), Pfu polymerase (family B), KOD polymerase (family B), and 9oN (family B); polymerases from family C such as Escherichia coli DNA Pol III and many others, polymerases from family D such as Pyrococcus furiosus DNA Pol II and many others; and polymerases from family X such as DNA Pol μ, DNA Pol β, DNA Pol σ, and many others.
[0094] Because the plasmonic nanostructure 18 is coupled to the polymerase 16 that performs the labeled nucleotide incorporation, the polymerase 16 at least partially defines the space between the dye label 26 and the plasmonic nanostructure 18. Thus, the size of the polymerase 16 can be selected to create a proximity-enhancing signal. In one example, the size of the polymerase 16 ranges from about 3 nm to about 9 nm. In another example, the size of the polymerase 16 ranges from about 4 nm to about 7 nm. In yet another example, the size of the polymerase 16 is about 5 nm.
[0095] In addition to the polymerase 16, the complex 14 also includes a plasmonic nanostructure 18 linked to the polymerase 16. The plasmonic nanostructure 18 of the complex 14 can be any of the examples described herein. The polymerase 16 has an active site for nucleotide incorporation, and it may be desirable to link the plasmonic nanostructure 18 to a region of the polymerase 16 away from the active site. For example, an internal or terminal tag distal to the active site may be desirable for attachment of the plasmonic nanostructure 18 so that the activity of the polymerase 16 is not inhibited. Any of the following techniques can be used to link the plasmonic nanostructure 18 to the polymerase 16.
[0096] In one example, the plasmonic nanostructure 18 is chemically conjugated to the polymerase 16. Chemical conjugation can be achieved with a binding pair, where the plasmonic nanostructure 18 is functionalized with a first member of the binding pair and the polymerase 16 includes or is functionalized with a second member of the binding pair. In exemplary binding pairs, the first and second members include a NiNTA (nickel-nitrilotriacetic acid) ligand and a histidine tag, or streptavidin or avidin and biotin, or a spitag and a spicatcher, or a maleimide and cysteine, or an azide and dibenzocyclooctyne (DBCO), respectively. Some of these examples involve chemical conjugation to an amine or cysteine present on the polymerase 16. Native or engineered cysteines on the polymerase 16 readily react with the surfaces of some functionalized plasmonic nanostructures (e.g., gold, silver, platinum, and alloys thereof). Native or engineered cysteines on polymerase 16 also readily react with maleimide groups incorporated into the surface of some functionalized plasmonic nanostructures. Any plasmonic nanoparticle can be functionalized with carboxyl groups, which can be activated with EDC (1-ethyl-3-[3-dimethylaminopropyl]carbodiimide hydrochloride) to react with naturally occurring or engineered amines on polymerase 16. N-hydroxysuccinimide esters (NHS esters) can be used to label amine groups on polymerase 16, such as lysines. In one example, N-hydroxysuccinimide (NHS) chemistry can be used in a pH range where only the N-terminal amine is reactive (e.g., pH 7), resulting in the addition of a single plasmonic nanostructure 18 to polymerase 16. Chemical conjugation can also be achieved by π-clamp-mediated cysteine conjugation, SUMO (small ubiquitin-like modifier) proteins, or any other suitable conjugation method.
[0097] In another example, the plasmonic nanostructure 18 is attached to the polymerase 16 via a hybridized oligonucleotide. This example is shown schematically in FIG. 2A. In this example, a single-stranded oligonucleotide 28 is attached to the polymerase 16, and its complementary single-stranded oligonucleotide tether 30 is attached to the plasmonic nanostructure 18. The oligonucleotide 28 hybridizes to the complementary oligonucleotide tether 30, linking the plasmonic nanostructure 18 to the polymerase 16. Any of the chemical conjugation techniques disclosed herein can be used to attach the oligonucleotide 28 to the polymerase 16 and the complementary oligonucleotide tether 30 to the plasmonic nanostructure 18. As two examples, thiolated oligonucleotides can be directly attached to the surface of gold or silver nanoparticles. Additionally, the complementary oligonucleotide tether 30 can be attached to the plasmonic nanostructure 18 through a variety of other chemistries, including azide-alkyne click reactions, copper-free click reactions, and aldehyde-functionalized oligoamine plasmonic nanostructure reactions.
[0098] Oligonucleotide 28 and complementary oligonucleotide tether 30 have the same length, which can range from about 5 nucleotides to about 30 nucleotides.
[0099] In this example, the polymerase 16 and hybridized oligonucleotides 28 and 30 at least partially define the distance between the dye label 26 and the plasmonic nanostructure 18. Thus, the size of the polymerase 16 and the length of the oligonucleotides 28 and 30 can be selected such that during imaging, the plasmonic nanostructure 18 is brought into a signal that enhances the proximity of the dye label 26.
[0100] In yet another example, the plasmonic nanostructure 18 is coupled to the polymerase 16 via an oligonucleotide tether 32 that wraps around the plasmonic nanostructure 18. The oligonucleotide tether 32 includes a portion 34 long enough to wrap around the plasmonic nanostructure 18 and a portion 36 complementary to the oligonucleotide 28 bound to the polymerase 16. The length of the portion 34 long enough to wrap around the plasmonic nanostructure 18 will depend on the size of the plasmonic nanostructure 18. In one example, the plasmonic nanostructure 18 has a diameter ranging from about 5 nm to about 12 nm, and the portion 34 long enough to wrap around the plasmonic nanostructure 18 can include about 40 nucleotides to about 150 nucleotides. These nucleotides can selectively bind to the surface of the plasmonic nanostructure 18. In one example, the plasmonic nanostructure 18 is gold, and the portion 34 long enough to wrap around the plasmonic nanostructure 18 is poly-adenine.
[0101] Complementary portion 36 of oligonucleotide tether 32 hybridizes to oligonucleotide 28 on polymerase 16, linking plasmonic nanostructure 18 wrapped around portion 34 to polymerase 16. In this example, complementary portion 36 and oligonucleotide 28 have the same length, which can range from about 5 nucleotides to about 20 nucleotides. Any of the chemical conjugation techniques disclosed herein can be used to attach oligonucleotide 28 to polymerase 16.
[0102] In this example, the polymerase 16 and hybridized oligonucleotide 28 and moiety 36 at least partially define the distance between the dye label 26 and the plasmonic nanostructure 18. Thus, the size of the polymerase 16 and the length of the oligonucleotide 28 and moiety 36 can be selected such that during imaging, the plasmonic nanostructure 18 is brought into a signal that enhances the proximity of the dye label 26.
[0103] In some examples, the conjugate 14 may also include additional components to improve retention of the conjugate 14 in the flow cell after a wash cycle.
[0104] In one example for improving complex retention after wash cycles, complex 14 includes a DNA-binding domain genetically fused to polymerase 16. In one example, the DNA-binding domain can include a single-stranded DNA (ss-DNA)-binding domain, which can bind, for example, to an adapter portion of a template strand in a flow cell. The ss-DNA-binding domain can be non-sequence specific. Examples of these DNA-binding domains include an oligonucleotide / oligosaccharide / oligopeptide binding (OB) fold, a K-homology (KH) domain, an RNA recognition motif (RRM), and a whirly domain. In another example, the DNA-binding domain can include a double-stranded DNA (ds-DNA)-binding domain, which can bind, for example, to the double-stranded portion of a sequencing primer / template duplex. Examples of these DNA-binding domains include the TOPO-V helix-hairpin-helix domain and PCNA (proliferating cell nuclear antigen).
[0105] In another example to improve complex retention after wash cycles, complex 14 can include a surface tether 42 (shown in FIG. 3 ). Surface tether 42 is used to immobilize complex 14 to a patterned or non-patterned flow cell surface 44 during incorporation and imaging. In one example, polymerase 16 includes surface tether 42 bound to its surface, and a flow cell surface binding agent binds to surface tether 42 (e.g., at the end opposite to where polymerase 16 is bound). In this example, flow cell surface 44 is functionalized to bind polymerase-bound surface tether 42 when polymerase 16 is introduced to the flow cell. In another example, flow cell includes surface tether 42 bound to its surface 44, and a polymerase binding agent binds to surface tether 42. In this example, the polymerase surface is functionalized to bind to flow cell-bound surface tether 42 when polymerase 16 is introduced to the flow cell. In any of these examples, surface tether 42 may comprise one member of a binding pair, with polymerase 16 bearing the other member: biotin / avidin, maltose binding protein / maltose, His6 / NiNTA, Spycatcher002 / Spytag002, or glutathione S-transferase / glutathione.
[0106] One specific example of a suitable surface tether 42 includes biotin-polyethylene glycol (PEG)-biotin. In this example, the biotin end of surface tether 42 can be conjugated to streptavidin or avidin located on the surface of polymerase 16 and on flow cell surface 44, respectively. Thus, in this example, the biotin at one end is the flow cell surface binding agent. Another specific example of a suitable surface tether 42 includes an avidin protein on flow cell surface 44. In this example, polymerase 16 can be biotinylated. Yet another specific example of a suitable surface tether 42 includes halogen-polyethylene glycol (PEG). In this example, PEG can be attached to flow cell surface 44, and the halogen can be attached to HaloTag® attached to polymerase 16.
[0107] The length of surface tether 42 is sufficient to allow surface-bound polymerase 16 to bind anywhere at junction 46 between template strand 48 and sequencing primer 50 or a growing nascent strand 52 extending from sequencing primer 50. In one example, surface tether 42 can have a length ranging from about 2 nm to about 200 nm, or from about 5 nm to about 150 nm, or from about 10 nm to about 100 nm, depending in part on the length of the library fragments to be sequenced on flow cell surface 44.
[0108] Referring again to Figure 1, in addition to complex 14, incorporation mixture 10A shown in Figure 1 also includes labeled nucleotide 20. As referred to herein, labeled nucleotide 20 includes nucleotide 22, a 3'OH blocking group 24 attached to the sugar of nucleotide 22, and a dye label 26 attached to the base of nucleotide 22. Some examples of labeled nucleotides 20A, 20B, 20C are shown in Figure 4.
[0109] Nucleotide 22 of labeled nucleotide 20 comprises a nitrogenous heterocyclic base, a sugar, and one or more phosphate groups. Nucleotide 22 is a monomeric unit of a nucleic acid sequence. In RNA, the sugar is ribose, and in DNA, the sugar is deoxyribose, i.e., a sugar lacking the hydroxyl group present at the 2' position of the ribose. The nitrogenous heterocyclic base (i.e., nucleobase) can be a purine or pyrimidine base. Purine bases include adenine (A) and guanine (G), as well as modified derivatives or analogs thereof. Pyrimidine bases include cytosine (C), thymine (T), and uracil (U), as well as modified derivatives or analogs thereof. The C-1 atom of ribose or deoxyribose is bound to the N-1 of the pyrimidine or the N-9 of the purine. Nucleotide 22 can be a monophosphate or a polyphosphate containing several phosphate groups (e.g., triphosphate (i.e., gamma phosphate), tetraphosphate, pentaphosphate, hexaphosphate, etc.). Nucleic acid analogs may have variations in either the phosphate backbone, sugar, or nucleobase. Examples of nucleic acid analogs include universal base or phosphate-sugar backbone analogs, such as peptide nucleic acid (PNA). In Figure 4, the base of nucleotide 22 is cytosine, the sugar is deoxyribose, and the phosphate is triphosphate or gamma phosphate.
[0110] Nucleotide 22 of labeled nucleotide 20 also includes a 3'OH blocking group 24 attached thereto. The 3'OH blocking group 24 can be linked to the 3' oxygen atom of a sugar molecule in nucleotide 22. The 3'OH blocking group 24 can be a reversible terminator, which allows single-base incorporation to occur with each sequencing cycle. The reversible terminator stops additional bases from being incorporated into nascent strand 52 (FIG. 3), which is complementary to the template polynucleotide strand (also referred to herein as template strand 48 (FIG. 3)). This allows for the detection and identification of single incorporated bases. Subsequently, the 3'OH blocking group 24 can be removed, and additional sequencing cycles can be performed on each template polynucleotide strand. Examples of different 3'OH blocking groups 24 are shown in Figure 4 as reference numerals 24A, 24B, and 24C, including a 3'-ONH2 reversible terminator (shown in 24A), a 3'-O-allyl reversible terminator (i.e., -CH=CHCH2, shown in 24B), and a 3'-O-azidomethyl reversible terminator (i.e., -CH2N3, shown in 24C). Other suitable reversible terminators include o-nitrobenzyl ether, alkyl o-nitrobenzyl carbonate, ester moieties, other allyl moieties, acetals (e.g., tert-butoxy-ethoxy), MOM (-CHOCH3) moieties, 2,4-dinitrobenzenesulfenyl, tetrahydrofuranyl ether, 3' phosphate, ether, -F, -H2, -OCH3, -N3, -HCOCH3, and 2-nitrobenzene carbonate.
[0111] Nucleotide 22 of labeled nucleotide 20 also includes a dye label 26 attached to the base of nucleotide 22. Dye label 26 can be any optically detectable moiety, including luminescent, chemiluminescent, fluorescent, fluorogenic, chromophoric, and / or chromogenic moieties. Some examples of suitable optically detectable moieties include fluorescein labels, rhodamine labels, cyanine labels (e.g., Cy3, Cy5, etc.), and the ALEXA FLUOR® family of fluorescent dyes (from Molecular Probes, Inc.) and other fluorescent and fluorogenic dyes.
[0112] The dye label 26 may be attached to the base of the nucleotide 22 using any suitable linking molecule. In one example, the linking molecule has the formula -((CH2)2O) n - (where n is an integer from 2 to 50). Other examples of linking molecules are shown in Figure 4 as reference numerals 38A, 38B, and 38C. Linking molecules 38A, 38B, 38C include a cleavage site 40, identified by an arrow in Figure 4.
[0113] In one example, incorporation mixture 10A includes a mixture of different labeled nucleotides 20 containing different bases, e.g., A, T, G, C (and U or I). It may also be desirable to utilize different types of dye labels 26 for the different labeled nucleotides 20. For example, fluorescent or fluorogenic labels can be selected such that each label absorbs excitation radiation and / or emits fluorescence at a wavelength that is distinguishable from the other labels. Such distinguishable analogs provide the ability to simultaneously monitor the presence of different labels 26 in the same reaction mixture. In some examples, one of the four labeled nucleotides 20 in incorporation mixture 10A may not include a dye label 26, while the other three labeled nucleotides 20 include different dye labels 26.
[0114] Referring back to Figure 3, the following description relates to an exemplary method involving incorporation mixture 10A. Throughout this description, reference will be made to and a brief description of a flow cell. Examples of flow cells are shown in Figures 8A, 8B, and 8C and are described in more detail below with reference to those figures.
[0115] During sequencing, template strands 48 to be sequenced can be formed on the flow cell surface 44 using amplification primers (not shown in FIG. 3 ) immobilized on the flow cell surface 44. At the start of template strand formation, library templates can be prepared from any nucleic acid sample (e.g., a DNA sample or an RNA sample). DNA nucleic acid samples can be fragmented into similarly sized (e.g., less than 1000 bp) single-stranded DNA fragments. RNA nucleic acid samples can be used to synthesize complementary DNA (cDNA), and the cDNA can be fragmented into similarly sized (e.g., less than 1000 bp) single-stranded cDNA fragments. During preparation, adapters can be added to either end of the fragments. Reduced cycle amplification can introduce different motifs into the adapters, such as sequencing primer binding sites, indexes, and regions complementary to the amplification primers on the flow cell surface 44. In some examples, fragments from a single nucleic acid sample have the same adapters added to the fragments. The final library template includes DNA or cDNA fragments and adapters at both ends. The DNA or cDNA fragments represent a portion of the final library template to be sequenced.
[0116] A plurality of library templates may be introduced into the flow cell, for example, where the plurality of library templates hybridize to one of two amplification primers immobilized on the flow cell surface 44.
[0117] Cluster generation can then be performed. In one example of cluster generation, library templates are copied from the hybridized primers by 3' extension using a high-fidelity DNA polymerase. The original library templates are denatured, leaving the copies immobilized on the flow cell surface 44. Isothermal bridge amplification or some other form of amplification can be used to amplify the immobilized copies. For example, the copied templates loop over and hybridize to adjacent complementary primers, and the polymerase copies the copied templates to form a double-stranded bridge structure, which is denatured to form two single strands. These two strands loop over and hybridize to adjacent complementary primers and are extended again to form two new double-stranded loops. This process is repeated for each template copy through cycles of isothermal denaturation and amplification to create dense clonal clusters. Each cluster of double-stranded bridge structures is denatured. In one example, the reverse strand is removed by specific base cleavage, leaving the forward template strand. While a single template strand 48 is shown in Figure 3, clustering results in the formation of several template strands 48 immobilized on the flow cell surface 44 (e.g., in lanes as shown in Figure 8B, or in depressions as shown in Figure 8C). This example of clustering is called bridge amplification and is one example of amplification that can be performed. It should be understood that other amplification techniques, such as the Examp workflow (Illumina Inc.), can be used.
[0118] A sequencing primer 50 can be introduced that hybridizes to a complementary portion of the sequence of template strand 48. This sequencing primer 50 prepares template strand 48 for sequencing using incorporation mixture 10A.
[0119] An exemplary sequencing method includes introducing an incorporation mixture 10A into a flow cell containing a cluster of template strands 48 (with hybridized sequencing primers 50), where the incorporation mixture 10A includes a plurality of complexes 14 and a plurality of labeled nucleotides 20, whereby at least one polymerase 16 i) incorporates each one of the labeled nucleotides 20 into a nascent strand 52 along one of the template strands 48, and ii) maintains its linked plasmonic nanostructure 18 within proximity of each one of the labeled nucleotides 20, and optically images the incorporation while the plasmonic nanostructure 18 is maintained.
[0120] In this exemplary method, any instance of incorporation mixture 10A is introduced into a flow cell, for example, via an input port. When incorporation mixture 10A is introduced into the flow cell, mixture 10A enters the flow channel and contacts surface(s) 44 on which template strands 48 reside.
[0121] Incorporation mixture 10A is incubated in the flow cell, and labeled nucleotides 20 are incorporated by each polymerase 16 of complex 14. As shown in FIG. 3 , during incorporation, one of the labeled nucleotides 20 extends one sequencing primer 50 by each polymerase 16 and is incorporated into one nascent strand 52 complementary to one of the template strands 48. Incorporation is performed in a template-strand-dependent manner; thus, detection of the order and type of labeled nucleotides 20 added to nascent strand 52 can be used to determine the sequence of template strand 48. Incorporation occurs on at least some of the template strands 48 that traverse the flow cell surface 44 during a single sequencing cycle. Thus, on at least some of the template strands 48 spanning the flow cell, each polymerase 16 extends the hybridized sequencing primer 50 with only one of the labeled nucleotides 20 in incorporation mixture 10A.
[0122] The incorporated labeled nucleotide 20 contains a reversible termination property due to the presence of the 3'OH blocking group 24, terminating further sequencing primer extension once the labeled nucleotide 20 is added.
[0123] After a desired time of incubation and incorporation, the incorporation mixture 10A, including unincorporated labeled nucleotides 20, can be removed from the flow cell during a wash cycle. The wash cycle may involve a flow-through technique in which a wash solution (e.g., a buffer) is introduced into, through, and then exits the flow channel, e.g., by a pump or other suitable mechanism.
[0124] At least a portion of the incorporating polymerases 16 and their respective complexes 14 remain in place at the junction 46 between the template strand 48 and the last incorporated labeled nucleotide 20 after the wash cycle. In one example, about 20% to about 90% of the complexes 14 remain in the flow cell after the wash cycle. While an exemplary range is provided, it should be understood that the percentage of remaining complexes 14 may be greater or less depending on a variety of different factors. As mentioned herein, to increase the percentage of complexes 14 retained during and after the wash cycle, the complexes 14 can be tethered to the template strand 48 (e.g., via a DNA-binding domain) or to the flow cell surface 44 (e.g., via a surface tether 42). Because each retained complex 14 includes a plasmonic nanostructure 18, these plasmonic nanostructures 18 are also retained in place at the junction 46 between the template strand 48 and the last incorporated labeled nucleotide 20, as shown in FIG. 3 . Thus, the plasmonic nanostructures 18 are held within a signal enhancing proximity of the dye labels 26 after incorporation.
[0125] Without further incorporation, the recently incorporated labeled nucleotide 20 can be detected through an imaging event. During the imaging event, an illumination system (not shown) can provide excitation light to the flow cell surface 44. The dye labels 26 of the incorporated labeled nucleotide 20 emit a light signal in response to the excitation light. Furthermore, because the retained plasmonic nanostructures 18 are held within the signal enhancing proximity of the respective dye labels 26, the signal from the dye labels 26 can be enhanced through plasmonic resonance.
[0126] After imaging, a cleavage mixture can then be introduced into the flow cell. In this example, the cleavage mixture can i) remove the 3'OH blocking group 24 from the incorporated nucleotide 20, and ii) cleave the dye label 26 from the incorporated nucleotide 20. Examples of 3'OH blocking groups 24 and suitable deblocking agents / components in the cleavage mixture can include: ester moieties, which can be removed by base hydrolysis; allyl moieties, which can be removed with NaI, chlorotrimethylsilane, and NaSO or with Hg(II) in acetone / water; azidomethyl, which can be cleaved with phosphines such as tris(2-carboxyethyl)phosphine (TCEP) or tri(hydroxypropyl)phosphine (THP); acetals, such as tert-butoxy-ethoxy, which can be cleaved under acidic conditions; MOM (-CHOCH) moieties, which can be cleaved with LiBF and CHCN / HO; 2,4-dinitrobenzenesulfenyl, which can be cleaved with nucleophiles such as thiophenol and thiosulfate; tetrahydrofuranyl ethers, which can be cleaved with Ag(I) or Hg(II); and 3' phosphates, which can be cleaved by phosphatase enzymes (e.g., polynucleotide kinase). Examples of suitable dye-labeled cleaving agents / components in the cleavage mixture can include sodium periodate, which can cleave vicinal diols; phosphines such as tris(2-carboxyethyl)phosphine (TCEP) or tris(hydroxypropyl)phosphine (THP), which can cleave azidomethyl bonds; palladium and THP, which can cleave allyls; bases, which can cleave ester moieties; or any other suitable cleaving agent.
[0127] Washing with the cleavage mixture or subsequent washes can also remove retained complexes 14 that are not otherwise linked to template strands 48 or flow cell surface 44 .
[0128] Once complex 14 is linked to template strand 48 (e.g., via a DNA-binding domain) or to flow cell surface 44 (e.g., via surface tether 42), an additional complex-removing agent can be added to the cleavage mixture. The complex-removing agent relies on the bond formed between complex 14 and template strand 48 or between complex 14 and flow cell surface 44. Some of the exemplary dye-labeled cleavage agents described herein may be capable of cleaving complex 14. In one example, a biotin-streptavidin binding pair links surface tether 42 to flow cell surface 44. In this example, the complex-removing agent may be a combination of sodium dodecyl sulfate (SDS), urea, and biotin, or a formamide reagent comprising about 10% to about 50% by volume of formamide and an optional buffer, with the remainder being a salt buffer comprising sodium chloride, sodium citrate, and a biocompatible surfactant. In another example, an excess of binding pair members can disrupt the bond between the binding pair (e.g., between polymerase 16 and surface tether 42, or between surface tether 42 and flow cell surface 44), either of which leaves open a binding site on flow cell surface 44. In yet another example, a nuclease or allyl cleavage chemical can be added to cleave surface tether 42. In yet another example, exogenous DNA can be added to facilitate release of the DNA-binding domain from the surface-conjugated DNA.
[0129] Wash(es) may be performed between the various fluid delivery steps. The sequencing cycle may then be repeated "n" times to extend the sequencing primer 50 by n nucleotides, thereby detecting a sequence of length n. In some examples, paired-end sequencing may be used, in which the forward strand is sequenced and removed, and then the reverse strand is constructed and sequenced.
[0130] 5A, another example of an incorporation mixture 10B is shown schematically. This exemplary incorporation mixture 10B includes another example of a labeled nucleotide 20′. This labeled nucleotide 20′ includes a nucleotide 22, a 3′ OH blocking group 24 attached to the sugar of the nucleotide 22, a dye label 26 attached to the base of the nucleotide 22, and a plasmonic nanostructure 18 attached to the base of the nucleotide 22.
[0131] Any of the nucleotides 22, 3'OH blocking groups 24, and dye labels 26 described herein can be used to label nucleotides 20'. Additionally, any of the plasmonic nanostructures 18 described herein can be used to label nucleotides 20'.
[0132] In this example, a first linking molecule 38 attaches a dye label 26 to the base of nucleotide 22, and a second linking molecule 38' attaches a plasmonic nanostructure 18 to the base of nucleotide 22. The lengths of the first and second linking molecules 38, 38' can depend on how the linking molecules 38, 38' attach to the base. In some examples, the lengths range from about 1 nm to about 12 nm, or up to about 100 nm, where the distance associated with signal-enhancing proximity is between 0.1 nm and 100 nm.
[0133] The first and / or second linking molecule 38, 38′ may be any of the linking molecules described for linking the dye label 26 to the base, such as the spacer group —((CH)O) n- (n ranges from 2 to 50), or examples shown by reference numbers 38A, 38B, and 38C in Figure 4. In some examples, the first and / or second linking molecules 38, 38' are selected to be the same type of linker so that they can be cleaved using the same mechanism after incorporation and imaging. Another example of the second linking molecule 38' is ds-DNA (double-stranded DNA). The rigidity of ds-DNA linkers can be particularly desirable. In any of these examples, the second linking molecule 38' can include a terminal group that can be chemically conjugated to the plasmonic nanostructure 18. As one example, biotin can be added to the end of the second linking molecule 38', and the plasmonic nanostructure 18 can be functionalized with avidin or streptavidin, which can bind to biotin. As another example, a thiol can be added to the end of the second linking molecule 38', which can be directly attached to the surface of a gold nanoparticle.
[0134] 5A, this example of an incorporation mixture 10B also includes a liquid carrier 12 and a polymerase 16. The concentration of the polymerase 16 and / or labeled nucleotides 20' can range from about 50 nM to about 100 μM, from about 1 nM to about 50 μM, etc.
[0135] The liquid carrier 12 of the incorporation mixture 10B can be water and / or any of the buffers described herein.
[0136] The polymerase 16 of incorporation mixture 10B can be any of the examples provided herein. It should be understood that in these examples, the polymerase 16 in incorporation mixture 10B is not part of complex 14. Thus, the polymerase 16 is not bound to plasmonic nanostructure 18. Because the polymerase 16 and plasmonic nanostructure 18 are separate, the polymerase 16 in these examples may not be functionalized for tethering to template strand 48 (e.g., via a DNA binding domain) or flow cell surface 44 (e.g., via surface tether 42).
[0137] Referring now to FIG. 5B, another example of an incorporation mixture 10C is shown schematically. This exemplary incorporation mixture 10C includes another example of a labeled nucleotide 20'''. This labeled nucleotide 20''' includes a nucleotide 22, a 3'OH blocking group 24 attached to the sugar of the nucleotide 22, a dye label 26 attached to the base of the nucleotide 22, and a plasmonic nanostructure 18 attached to the dye label 26. The attachment of the plasmonic nanoparticle 18 to the dye label 26 may be less sterically packed than the exemplary labeled nucleotide 20' shown in FIG. 5A.
[0138] Any of the nucleotides 22, 3'OH blocking groups 24, and dye labels 26 described herein can be used to label nucleotides 20'". Additionally, any of the plasmonic nanostructures 18 described herein can be used to label nucleotides 20'".
[0139] In this example, a first linking molecule 38 attaches the dye label 26 to the base of the nucleotide 22, and a second linking molecule 38' attaches the plasmonic nanostructure 18 to the dye label 26. The overall length of the first and second linking molecules 38, 38' can depend on how the linking molecule 38 attaches to the base and how the linking molecule 38' attaches to the dye label 26. In some examples, the length of the linking molecule 38' ranges from about 1 nm to about 12 nm, or up to about 100 nm, where the distance associated with a proximity-enhancing signal is between 0.1 nm and 100 nm.
[0140] The first and / or second linking molecule 38, 38′ may be any of the linking molecules described for linking the dye label 26 to the base, such as the spacer group —((CH)O) n - (n is in the range of 2 to 50) or may be the examples shown by reference numerals 38A, 38B and 38C in FIG.
[0141] As shown in Figure 5B, this example of an incorporation mixture 10C also includes a liquid carrier 12 and a polymerase 16. The concentration of the polymerase 16 and / or labeled nucleotides 20''' can range from about 50 nM to about 100 µM, from about 1 nM to about 50 µM, etc.
[0142] Liquid carrier 12 of incorporation mixture 10C can be water and / or any of the buffers described herein. Liquid carrier 12 of incorporation mixture 10C can also include catalytic metal(s).
[0143] The polymerase 16 of incorporation mixture 10C can be any of the examples provided herein. It should be understood that in these examples, the polymerase 16 in incorporation mixture 10C is not part of complex 14. Thus, the polymerase 16 is not bound to plasmonic nanostructure 18. Because the polymerase 16 and plasmonic nanostructure 18 are separate, the polymerase 16 in these examples may not be functionalized for tethering to template strand 48 (e.g., via a DNA binding domain) or flow cell surface 44 (e.g., via surface tether 42).
[0144] 6, the following description relates to an exemplary method involving incorporation mixture 10B. This method also utilizes the example flow cell shown and described in detail with reference to Figures 8A, 8B, and 8C. At the start of the method, template strand 48 is formed as described with reference to Figure 3.
[0145] 6, a sequencing primer 50 can be introduced that hybridizes to a complementary portion of the sequence of template strand 48. This sequencing primer 50 makes template strand 48 ready for sequencing using incorporation mixture 10B.
[0146] An exemplary sequencing method includes introducing an incorporation mixture 10B into a flow cell containing a cluster of template strands 48 (to which sequencing primers 50 are hybridized), where the incorporation mixture 10B includes a liquid carrier 12, a plurality of polymerases 16, and a plurality of labeled nucleotides 20′, whereby at least one polymerase 16 incorporates individual ones of the labeled nucleotides 20′ into nascent strands 52 along one of the template strands 48 and optically imaging the incorporation.
[0147] In this exemplary method, any instance of incorporation mixture 10B is introduced into the flow cell, for example, via an input port. When incorporation mixture 10B is introduced into the flow cell, mixture 10B enters the flow channel and contacts surface(s) 44 on which template strands 48 reside.
[0148] Incorporation mixture 10B is incubated in the flow cell, and labeled nucleotides 20′ are incorporated by respective polymerases 16. As shown in FIG. 6 , during incorporation, one of the labeled nucleotides 20′ extends one sequencing primer 50 by a respective polymerase 16 and is incorporated into one nascent strand 52 that is complementary to one of the template strands 48. This incorporation is also performed in a template strand-dependent manner, such that detection of the order and type of labeled nucleotides 20′ added to nascent strand 52 can be used to determine the sequence of template strand 48. Incorporation occurs on at least a portion of the template strands 48 that traverse the flow cell surface 44 during a single sequencing cycle.
[0149] The incorporated labeled nucleotide 20' contains a reversible termination property due to the presence of the 3'OH blocking group 24, terminating further sequencing primer extension once the labeled nucleotide 20' is added.
[0150] After a desired time of incubation and incorporation, the incorporation mixture 10B, including unincorporated labeled nucleotides 20', can be removed from the flow cell during a wash cycle, which may involve a flow-through technique in which a wash solution (e.g., a buffer) is introduced into, through, and then exits the flow channel, e.g., by a pump or other suitable mechanism.
[0151] Because each plasmonic nanostructure 18 is linked to an incorporated labeled nucleotide 20', these plasmonic nanostructures 18 are held in place within a signal enhancing proximity of the dye label 26 after incorporation.
[0152] Without further incorporation, the most recently incorporated labeled nucleotide 20' can be detected through an imaging event. During the imaging event, an illumination system (not shown) can provide excitation light to the flow cell surface 44. The dye labels 26 of the incorporated labeled nucleotides 20' emit light signals in response to the excitation light, and the plasmonic nanostructures 18 of each incorporated labeled nucleotide 20' enhance these light signals through plasmonic resonance.
[0153] After imaging, a cleavage mixture can then be introduced into the flow cell. In this example, the cleavage mixture can i) remove the 3'OH blocking group 24 from the incorporated nucleotide 20', ii) cleave the dye label 26 from the incorporated nucleotide 20', and iii) cleave the plasmonic nanostructure 18 from the incorporated nucleotide 20'.
[0154] In this example, any of the deblocking agents / components described herein for cleaving the 3′-OH blocking group 24 can be used. Also, in this example, any of the cleaving agents / components described herein for cleaving the dye label 26 can be used. If the linking molecules 38, 38′ used to attach the dye label 26 and the plasmonic nanostructure 18, respectively, are the same, the cleavage mixture can include a single cleaving agent / component capable of cleaving the linking molecules 38, 38′. If the linking molecules 38, 38′ used to attach the dye label 26 and the plasmonic nanostructure 18, respectively, are different, the cleavage mixture can include different cleaving agents / components capable of cleaving each linking molecule 38, 38′. As an example, a restriction enzyme that targets a specific sequence in each linking molecule 38, 38′ can be used.
[0155] Wash(es) may be performed between the various fluid delivery steps. The sequencing cycle may then be repeated n times to extend the sequencing primer 50 by n nucleotides, thereby detecting a sequence of length n. In some examples, paired-end sequencing may be used, in which the forward strand is sequenced and removed, and then the reverse strand is constructed and sequenced.
[0156] Incorporation mixture 10C may be used in the method described with reference to Figure 6 in place of incorporation mixture 10B. The method (e.g., incorporation, incubation, signal enhancement, etc.) would be similar to that described with reference to Figure 6, except that the cleavage process may be simplified. In incorporation mixture 10C, plasmonic nanostructures 18 are bound to dye labels 26. Thus, when dye labels 26 are cleaved, plasmonic nanostructures 18 are also cleaved. Therefore, no additional cleavage agent for linking molecule 38' is used during this method.
[0157] Imaging plasmonic nanostructures in mixtures In other examples disclosed herein, plasmonic nanostructures 18 may be included in the imaging mixture rather than in the incorporation mixture 10A, 10B, or 10C. In these examples, nanostructures 18 are functionalized to enable association with an incorporated labeled nucleotide (e.g., labeled nucleotide 20). In these examples, functionalization is at least part of the mechanism by which plasmonic nanostructures 18 are localized within signal-enhancing proximity of dye label 26.
[0158] 7A, 7B, and 7C show three examples of kits 54, 54', 54" that include both incorporation mixtures 10D, 10E, and 10F and imaging mixtures 56, 56', and 56". Each kit 54, 54', 54" includes a different example of incorporation mixture 10D, 10E, and 10F, including a liquid carrier 12, an example of polymerase 16 or 16", and an example of labeled nucleotide 20 or 20". Each kit 54, 54', 54" also includes an example of imaging mixture 56, 56', 56" that includes a second liquid carrier 12' and an example of a plasmonic nanostructure 18', 18", or 18'" that is functionalized for associating itself within proximity of the labeled nucleotide 20 or 20" after an incorporation event involving the labeled nucleotide 20 or 20".
[0159] The liquid carrier 12 of incorporation mixtures 10D, 10E, and 10F, and the second liquid carrier 12' of imaging mixtures 56, 56', 56'' may be water and / or any of the buffers described herein. The liquid carrier 12' may also include catalytic metal(s).
[0160] Each of these exemplary kits 54, 54', 54" can be used in a sequencing method that generally includes: introducing incorporation mixtures 10D, 10E, and 10F into a flow cell containing a cluster of template strands 48, whereby at least one of polymerases 16 or 16" incorporates a respective one of labeled nucleotides 20 or 20" into nascent strand 52 along one of the template strands 48; introducing imaging mixture 56, 56', or 56" into the flow cell, whereby at least one functionalized plasmonic nanostructure 18', 18", or 18'" associates itself within proximity of a respective one of labeled nucleotides 20 or 20", and optically imaging the incorporation while at least one functionalized plasmonic nanostructure 18', 18", or 18'" is associated with the respective one of labeled nucleotides 20 or 20".
[0161] Each of the kits 54, 54', 54'' and their associated sequencing methods are further described with reference to Figures 7A, 7B, and 7C, respectively.
[0162] In the exemplary kit 54 shown in Figure 7A, incorporation mixture 10D includes a polymerase 16 as described with reference to Figure 5A and includes labeled nucleotides 20 as described with reference to Figure 1. The polymerase 16 may be any of the embodiments disclosed herein for use in incorporation and may not be functionalized for tethering to a template strand 48 (e.g., via a DNA-binding domain) or to a flow cell surface 44 (e.g., via a surface tether 42). The polymerase 16 is used to incorporate labeled nucleotides 20 during an incorporation event, as described with reference to Figure 6. It should be understood that incorporation mixture 10D includes multiple polymerases 16.
[0163] 7A, the imaging mixture 56 includes a plasmonic nanostructure 18' functionalized with a second polymerase 16'. The plasmonic nanostructure 18' functionalized with a second polymerase 16' is similar to complex 14, except that the second polymerase 16' is not utilized to incorporate a labeled nucleotide 20, but rather is utilized to localize the plasmonic nanostructure 18' near the junction 46 between the template strand 48 and the last incorporated labeled nucleotide 20 after incorporation has occurred.
[0164] The second polymerase 16' can be any example of a polymerase 16 described herein, or it can be a polymerase that is inactive for nucleotide incorporation. Any of the polymerases described herein can be exposed to an active site mutation that renders the second polymerase 16' unable to catalyze the incorporation reaction. The polymerases share a common mechanism using two active site aspartic acid residues, and mutating one or both of these residues renders the second polymerase 16' inactive for polymerization. The second polymerase 16' is also selected so that it can specifically bind to the 3' end of the nascent strand 52.
[0165] The plasmonic nanostructure 18' is coupled to a second polymerase 16' that specifically binds to the 3' end of the nascent strand 52, so that the polymerase 16' at least partially defines the space between the dye label 26 (of the incorporated nucleotide 20) and the plasmonic nanostructure 18'. Thus, the size of the polymerase 16' can be selected to create a proximity-enhancing signal. In one example, the size of the polymerase 16' ranges from about 3 nm to about 12 nm. In another example, the size of the polymerase 16' ranges from about 4 nm to about 7 nm. In yet another example, the size of the polymerase 16' is about 5 nm. Where the distance associated with the proximity-enhancing signal is between 0.1 nm and 100 nm, the size of the polymerase 16' may be larger, e.g., up to about 100 nm.
[0166] The second polymerase 16' may be coupled to the plasmonic nanostructure 18' using the same techniques described herein for coupling the polymerase 16 to the plasmonic nanoparticle 18. In one example, the second polymerase 16' may be coupled to the plasmonic nanostructure 18' using any of the chemical conjugation techniques described herein. In another example, a coupling similar to that shown in FIG. 2A is used where an oligonucleotide 28 is coupled to the second polymerase 16'. In yet another example, a coupling similar to that shown in FIG. 2B is used where an oligonucleotide 28 is coupled to the second polymerase 16' and an oligonucleotide tether 32 is wrapped around the plasmonic nanoparticle 18'.
[0167] The following description relates to an exemplary method that includes kit 54. The method also utilizes the example flow cell shown and described with reference to Figures 8A, 8B, and 8C. At the start of the method, template strand 48 is formed as described with reference to Figure 3.
[0168] A sequencing primer 50 can be introduced that hybridizes to a complementary portion of the sequence of template strand 48. This sequencing primer 50 makes template strand 48 ready for sequencing using incorporation mixture 10D and imaging mixture 56.
[0169] In this exemplary method, incorporation mixture 10D is introduced into the flow cell, for example, via an input port. When incorporation mixture 10D is introduced into the flow cell, mixture 10D enters the flow channel and contacts surface(s) 44 on which template strands 48 reside.
[0170] Incorporation mixture 10D is incubated in the flow cell, and labeled nucleotides 20 are incorporated by respective polymerases 16. Similar to the example shown in Figure 6, during incorporation, one of the labeled nucleotides 20 extends one sequencing primer 50 by the respective polymerase 16 and is incorporated into one nascent strand 52 complementary to one of the template strands 48. This incorporation is also performed in a template strand-dependent manner, such that detection of the order and type of labeled nucleotides 20 added to nascent strand 52 can be used to determine the sequence of template strand 48. Incorporation occurs on at least a portion of the template strands 48 that traverse the flow cell surface 44 during a single sequencing cycle.
[0171] The incorporated labeled nucleotide 20 contains a reversible termination property due to the presence of the 3'OH blocking group 24, terminating further sequencing primer extension once the labeled nucleotide 20 is added.
[0172] After the desired time of incubation and incorporation, the incorporation mixture 10D, including unincorporated labeled nucleotides 20, can be removed from the flow cell during a wash cycle. The incorporation mixture 10D is removed before introducing the imaging mixture 56. In this example, it is desirable to remove most, if not all, of the polymerase 16 from the incorporation mixture 10D during the wash cycle. Multiple wash cycles can be performed to increase the proportion of polymerase 16 that is removed. The wash cycle(s) can include the flow-through techniques described herein.
[0173] The imaging mixture 56 is then introduced into the flow cell, for example, via an input port. When the imaging mixture 56 is introduced into the flow cell, the mixture 56 enters the flow channel and contacts the surface(s) 44 on which the template strand 48 containing the most recently incorporated labeled nucleotide 20 resides.
[0174] The imaging mixture 56 is incubated in the flow cell, and at least some of the second polymerases 16' specifically bind to the 3' ends of at least some of the nascent strands 52. Because each plasmonic nanostructure 18' is functionalized with a second polymerase 16', each plasmonic nanostructure 18' is brought into signal proximity enhancement of the dye label 26 when the bound second polymerase 16' specifically binds to the 3' end of a nascent strand 52. Furthermore, labeled nucleotides 20 are not introduced with the imaging mixture 56, and therefore, incorporation of additional labeled nucleotides 20 does not occur.
[0175] Without further incorporation, the most recently incorporated labeled nucleotide 20 can be detected through an imaging event. During the imaging event, an illumination system (not shown) can provide excitation light to the flow cell surface 44. The dye labels 26 of the incorporated labeled nucleotides 20 emit light signals in response to the excitation light, and the respective plasmonic nanostructures 18′ immobilized by the second polymerase 16′ enhance these light signals through plasmonic resonance.
[0176] After imaging, a cleavage mixture can then be introduced into the flow cell. In this example, the cleavage mixture can i) remove the 3'OH blocking group 24 from the incorporated nucleotide 20, ii) cleave the dye label 26 from the incorporated nucleotide 20, and iii) remove the second polymerase 16' and its bound plasmonic nanoparticle 18'.
[0177] In this example, any of the deblocking agents / components described herein for cleaving the 3'OH blocking group 24 can be used. Also, in this example, any of the cleaving agents / components described herein for cleaving the dye label 26 can be used.
[0178] Wash(es) may be performed between the various fluid delivery steps. The sequencing cycle may then be repeated n times to extend the sequencing primer 50 by n nucleotides, thereby detecting a sequence of length n. In some examples, paired-end sequencing may be used, in which the forward strand is sequenced and removed, and then the reverse strand is constructed and sequenced.
[0179] In the exemplary kit 54' shown in FIG. 7B, the incorporation mixture 10E includes a polymerase 16'' and labeled nucleotides 20, as described with reference to FIG.
[0180] In this example, polymerase 16" is used to incorporate labeled nucleotide 20 as well as bind plasmonic nanoparticle 18" that is introduced into imaging mixture 56'. Thus, polymerase 16" is any of the embodiments disclosed herein for use in nucleotide incorporation and is also functionalized with one member of a binding pair 58A. Because it is desirable for polymerase 16" to remain in place after incorporation, polymerase 16" can also be functionalized for tethering to template strand 48 (e.g., via a DNA binding domain) or to flow cell surface 44 (e.g., via surface tether 42). Any of the examples of surface tether 42 described herein can be used to immobilize polymerase 16". It should be understood that incorporation mixture 10E includes multiple polymerases 16".
[0181] Because the plasmonic nanostructure 18'' ultimately binds to the polymerase 16'' used for incorporation, the polymerase 16'' at least partially defines the space between the dye label 26 (of the incorporated nucleotide 20) and the plasmonic nanostructure 18''. Thus, the size of the polymerase 16'' can be selected to create a proximity-enhancing signal. In one example, the size of the polymerase 16'' ranges from about 3 nm to about 9 nm. In another example, the size of the polymerase 16'' ranges from about 4 nm to about 7 nm. In yet another example, the size of the polymerase 16'' is about 5 nm.
[0182] Also shown in FIG. 7B is an exemplary kit 54′, in which the imaging mixture 56′ includes a plasmonic nanostructure 18″ functionalized with another member 58B of a binding pair. Member 58B on the plasmonic nanoparticle 18″ can bind to member 58A on the polymerase 16″. Exemplary binding pairs include NiNTA (nickel-nitrilotriacetic acid) ligand and histidine tag, or streptavidin or avidin and biotin, or spy tag and spy catcher, or maleimide and cysteine, or azide and dibenzocyclooctyne (DBCO), respectively.
[0183] The following description relates to an exemplary method including kit 54', which also utilizes the example flow cell shown and described in detail with reference to Figures 8A, 8B, and 8C. At the start of the method, template strand 48 is formed as described with reference to Figure 3.
[0184] A sequencing primer 50 can be introduced that hybridizes to a complementary portion of the sequence of template strand 48. This sequencing primer 50 makes template strand 48 ready for sequencing using incorporation mixture 10E and imaging mixture 56'.
[0185] In this exemplary method, incorporation mixture 10E is introduced into a flow cell, for example, via an input port. When incorporation mixture 10E is introduced into the flow cell, mixture 10E enters the flow channel and contacts surface(s) 44 on which template strands 48 reside.
[0186] Incorporation mixture 10E is incubated in the flow cell, and labeled nucleotides 20 are incorporated by respective polymerases 16''. Similar to the example shown in Figure 6, during incorporation, one of the labeled nucleotides 20 extends one sequencing primer 50 by a respective polymerase 16'' and is incorporated into one nascent strand 52 complementary to one of the template strands 48. This incorporation is also performed in a template strand-dependent manner; therefore, detection of the order and type of labeled nucleotides 20 added to nascent strand 52 can be used to determine the sequence of template strand 48. Incorporation occurs on at least a portion of the template strands 48 that traverse the flow cell surface 44 during a single sequencing cycle.
[0187] The incorporated labeled nucleotide 20 contains a reversible termination property due to the presence of the 3'OH blocking group 24, terminating further sequencing primer extension once the labeled nucleotide 20 is added.
[0188] After the desired time of incubation and incorporation, the incorporation mixture 10E, including any unincorporated labeled nucleotides 20, can be removed from the flow cell during a wash cycle. The incorporation mixture 10E is removed prior to introducing the imaging mixture 56'. At least a portion of the incorporating polymerase 16 remains in place at the junction 46 between the template strand 48 and the last incorporated labeled nucleotide 20 after the wash cycle. In one example, about 20% to about 90% of the polymerase 16'' remains in the flow cell after the wash cycle. As mentioned herein, to increase the percentage of polymerase 16'' retained during and after the wash cycle, the polymerase 16'' can be tethered to the template strand 48 (e.g., via a DNA-binding domain) or to the flow cell surface 44 (e.g., via a surface tether 42).
[0189] The imaging mixture 56' is then introduced into the flow cell, for example, via an input port. When the imaging mixture 56' is introduced into the flow cell, the mixture 56' enters the flow channel and contacts the surface(s) 44 on which the template strand 48 containing the most recently incorporated labeled nucleotide 20 resides.
[0190] The imaging mixture 56′ is incubated in the flow cell, and at least some of the members 58B of the plasmonic nanostructure 18″ bind to members 58A of the polymerase 16″ that remain at the junction 46 between the template strand 48 and the most recently incorporated labeled nucleotide 20. Thus, the plasmonic nanostructure 18″ is brought into signal proximity of the dye label 26 when its members 58B specifically bind to members 58A on the polymerase 16″.
[0191] Without further incorporation, the most recently incorporated labeled nucleotide 20 can be detected through an imaging event. During the imaging event, an illumination system (not shown) can provide excitation light to the flow cell surface 44. The dye labels 26 of the incorporated labeled nucleotides 20 emit light signals in response to the excitation light, and the respective plasmonic nanostructures 18" immobilized by the polymerase 16" enhance these light signals through plasmonic resonance.
[0192] After imaging, a cleavage mixture can then be introduced into the flow cell. In this example, the cleavage mixture can i) remove the 3'OH blocking group 24 from the incorporated nucleotide 20, ii) cleave the dye label 26 from the incorporated nucleotide 20, and iii) remove the polymerase 16" and its bound plasmonic nanoparticle 18".
[0193] In this example, any of the deblocking agents / components described herein for cleaving the 3′OH blocking group 24 can be used. Also, in this example, any of the cleaving agents / components described herein for cleaving the dye label 26 can be used. Once the polymerase 16″ is linked to the template strand 48 (e.g., via the DNA binding domain) or to the flow cell surface 44 (e.g., via the surface tether 42), an additional polymerase removing agent described herein can be added to the cleavage mixture. The polymerase removing agent relies on the bond formed between the polymerase 16″ and the template strand 48 or between the polymerase 16″ and the flow cell surface 44. In one example, a biotin-streptavidin binding pair links the surface tether 42 (and the polymerase 16″) to the flow cell surface 44. In this example, the polymerase remover can be sodium dodecyl sulfate (SDS), a combination of urea and biotin, or a formamide reagent comprising about 10% to about 50% by volume of formamide and an optional buffer, with the remainder being a salt buffer comprising sodium chloride, sodium citrate, and a biocompatible surfactant.
[0194] Wash(es) may be performed between the various fluid delivery steps. The sequencing cycle may then be repeated n times to extend the sequencing primer 50 by n nucleotides, thereby detecting a sequence of length n. In some examples, paired-end sequencing may be used, in which the forward strand is sequenced and removed, and then the reverse strand is constructed and sequenced.
[0195] In the exemplary kit 54'' shown in Figure 7C, the incorporation mixture 10F includes a polymerase 16, as described in Figure 5A, and another example of a labeled nucleotide 20''.
[0196] In this example of incorporation mixture 10F, polymerase 16 may be any of the embodiments disclosed herein for use in incorporation and may not be functionalized for tethering to template strand 48 (e.g., via a DNA binding domain) or to flow cell surface 44 (e.g., via surface tether 42). Polymerase 16 is used to incorporate labeled nucleotide 20'' during the incorporation event, as described with reference to FIG. 6. It should be understood that incorporation mixture 10F includes multiple polymerases 16.
[0197] Labeled nucleotide 20" comprises nucleotide 22, a 3'OH blocking group 24 attached to the sugar of nucleotide 22, and a dye label 26 attached to the base of nucleotide 22. Labeled nucleotide 20" is also biotinylated and therefore comprises a biotin label 60. Biotin label 60 can be linked to a suitable linking molecule, such as a nucleotide of the formula -((CH2)2O) n The biotin label 60 may be attached to the base of the labeled nucleotide 20" via a spacer group of - (where n is an integer between 2 and 50), a PEG linker, or any of the linking molecules 38A, 38B, 38C shown in Figure 4. Alternatively, the biotin label 60 may be incorporated past (i.e., attached to) the dye label 26.
[0198] The plasmonic nanostructure 18''' ultimately binds to the biotin label 60 of the labeled nucleotide 20'', and therefore the length of the linking molecule bound to the biotin label 60 can be selected such that the bound plasmonic nanostructure 18''' is within a signal that enhances the proximity of the dye label 26 of the labeled nucleotide 20''. In one example, the biotin-labeled linking molecule has a length within about 3 nm to about 12 nm of the length of the dye-labeled linking molecule 38. In another example, the biotin-labeled linking molecule has a first length and the dye-labeled linking molecule 38 has a second length, the first and second lengths being in the range of about 3 nm to about 12 nm.
[0199] Also shown in FIG. 7C is an exemplary kit 54″, in which the imaging mixture 56″ includes plasmonic nanostructures 18′″ functionalized with streptavidin 62. The streptavidin 62 on the plasmonic nanostructures 18′″ and the biotin label 60 on the labeled nucleotide 20″ form a binding pair.
[0200] The following description relates to an exemplary method that includes kit 54'', which also utilizes the example flow cell shown and described in detail with reference to Figures 8A, 8B, and 8C. At the start of the method, template strand 48 is formed as described with reference to Figure 3.
[0201] A sequencing primer 50 can be introduced that hybridizes to a complementary portion of the sequence of template strand 48. This sequencing primer 50 makes template strand 48 ready for sequencing using incorporation mixture 10F and imaging mixture 56''.
[0202] In this exemplary method, incorporation mixture 10F is introduced into a flow cell, for example, via an input port. When incorporation mixture 10F is introduced into the flow cell, mixture 10F enters the flow channel and contacts surface(s) 44, where template strand 48 (to which sequencing primer 50 hybridizes) resides.
[0203] Incorporation mixture 10F is incubated in the flow cell, and labeled nucleotides 20" are incorporated by the respective polymerases 16. Similar to the example shown in FIG. 6, during incorporation, one of the labeled nucleotides 20" extends one sequencing primer 50 by the respective polymerase 16 and is incorporated into one nascent strand 52 complementary to one of the template strands 48. This incorporation is also performed in a template strand-dependent manner; therefore, detection of the order and type of labeled nucleotides 20" added to nascent strand 52 can be used to determine the sequence of template strand 48. Incorporation occurs on at least a portion of the template strands 48 that traverse the flow cell surface 44 during a single sequencing cycle.
[0204] The incorporated labeled nucleotide 20'' contains a reversible termination property due to the presence of the 3'OH blocking group 24, terminating further sequencing primer extension once the labeled nucleotide 20'' is added.
[0205] After the desired time of incubation and incorporation, the incorporation mixture 10F, including any unincorporated labeled nucleotides 20", may be removed from the flow cell during a wash cycle. The incorporation mixture 10F is removed prior to introducing the imaging mixture 56". In this example, it is desirable to remove most, if not all, of the polymerase 16 from the incorporation mixture 10F during the wash cycle. Multiple wash cycles can be performed to increase the proportion of polymerase 16 that is removed. The wash cycle(s) may include the flow-through techniques described herein.
[0206] The imaging mixture 56" is then introduced into the flow cell, for example, via an input port. When the imaging mixture 56" is introduced into the flow cell, the mixture 56" enters the flow channel and contacts the flow cell surface(s) 44 on which the template strand 48 containing the most recently incorporated labeled nucleotide 20" resides.
[0207] The imaging mixture 56'' is incubated in the flow cell, and at least some of the plasmonic nanoparticles 18'' specifically bind, via streptavidin 62 on their surface, to biotin labels 60 on at least some of the incorporated nucleotides 20''. Because the biotin labels 60 are part of the labeled nucleotides 20'' to which the plasmonic nanoparticles 18'' are bound, the plasmonic nanostructures 18' are brought into signal enhancement of the proximity of the dye labels 26 of the labeled nucleotides 20''.
[0208] Without further incorporation, the recently incorporated labeled nucleotide 20" can be detected through an imaging event. During the imaging event, an illumination system (not shown) can provide excitation light to the flow cell surface 44. The dye labels 26 of the incorporated labeled nucleotides 20" emit optical signals in response to the excitation light, and the respective plasmonic nanostructures 18'" are immobilized by the interaction between streptavidin 62 and biotin labels 60, enhancing these optical signals through plasmonic resonance.
[0209] After imaging, a cleavage mixture can then be introduced into the flow cell. In this example, the cleavage mixture can i) remove the 3'OH blocking group 24 from the incorporated nucleotide 20', ii) cleave the dye label 26 from the incorporated nucleotide 20', and iii) cleave the biotin label 60 from the incorporated nucleotide 20'.
[0210] In this example, any of the deblocking agents / components described herein for cleaving 3'OH blocking group 24 can be used. Also, in this example, any of the cleaving agents / components described herein for cleaving dye label 26 can be used. If the biotin-labeled linking molecule is the same as dye-labeled linking molecule 38, the cleavage mixture can include a single cleaving agent / component capable of cleaving both biotin label 60 and dye label 26. If the biotin-labeled linking molecule is different from dye-labeled linking molecule 38, the cleavage mixture can include different cleaving agents / components capable of cleaving each linking molecule.
[0211] Wash(es) may be performed between the various fluid delivery steps. The sequencing cycle may then be repeated n times to extend the sequencing primer 50 by n nucleotides, thereby detecting a sequence of length n. In some examples, paired-end sequencing may be used, in which the forward strand is sequenced and removed, and then the reverse strand is constructed and sequenced.
[0212] Flow cell Examples of flow cells that may be used in the embodiments disclosed herein will now be described with reference to Figures 8A, 8B, and 8C.
[0213] A top view of an example flow cell 64 is shown in FIG. 8A. As described with reference to FIGS. 8B and 8C, some examples of flow cells 64 include two opposing flow cell surfaces 44 on which sequencing can occur. An example of an unpatterned sequencing surface 44A, 44A' is shown in FIG. 8B, and an example of a patterned sequencing surface 44B, 44B' is shown in FIG. 8C. Each sequencing surface 44A, 44A', or 44B, 44B' is supported by a substrate (generally shown as 66 in FIG. 8A), and a flow channel (generally shown as 68 in FIG. 8A) is defined between the sequencing surfaces 44A, 44A' or 44B, 44B'. In other examples, the flow cell 64 includes one sequencing surface 44A or 44B supported by a substrate 66 and a lid attached to the substrate 66. In these examples, a flow channel 68 is defined between the sequencing surface 44A or 44B and the lid.
[0214] In either example, the substrate 66 may be a single layer / material. Examples of single layer substrates are shown in FIG. 8B with reference numerals 66A and 66A'. Examples of suitable single layer substrates 66A, 66A' include epoxy siloxane, glass, modified or functionalized glass, plastics (including acrylic, polystyrene, copolymers of styrene and other materials, polypropylene, polyethylene, polybutylene, polyurethane, polytetrafluoroethylene (such as TEFLON® from Chemours), cyclic olefin / cycloolefin polymers (COP) (such as ZEONOR® from Zeon), polyimides, etc.), nylon (polyamide), ceramic / ceramic oxide, silica, fused silica, or silica-based materials, aluminum silicate, silicon and modified silicon (e.g., boron-doped p+ silicon), silicon nitride (Si3N4), silicon oxide (SiO2), tantalum pentoxide (Ta2O5) or other tantalum oxides (TaO x), hafnium oxide (HfO2), carbon, metal, inorganic glass, etc.
[0215] The substrate 66 may also be a multilayer structure. Examples of multilayer substrates are shown in FIG. 8C, reference numerals 66B and 66B′. Some examples of the multilayer structure 66B, 66B′ include glass or silicon with a coating layer of tantalum pentoxide or another oxide that is equivalent to the light used for optical imaging. With particular reference to FIG. 8C, another example of the multilayer structure 66B, 66B′ includes a lower support 70, 70′ with a patterned resin 72, 72′ thereon. Yet another example of the multilayer substrate 66B, 66B′ may include a silicon-on-insulator (SOI) substrate.
[0216] In one example, the substrate 66 (whether single layer or multilayer) may be circular, have a diameter ranging from about 2 mm to about 300 mm, or may comprise a rectangular sheet or panel having a maximum dimension of up to about 10 feet (about 3 meters). In one example, the substrate 66 is a wafer having a diameter ranging from about 200 mm to about 300 mm. In another example, the substrate 66 is a die having a width ranging from about 0.1 mm to about 10 mm. While exemplary dimensions are provided, it should be understood that a substrate 66 having any suitable dimensions can be used. As another example, a panel may be used that is a rectangular support having a surface area greater than a 300 mm round wafer.
[0217] In the example shown in FIG. 8A, flow cell 64 includes flow channels 68. While several flow channels 68 are shown, it should be understood that any number of channels 68 can be included in flow cell 64 (e.g., a single channel 68, four channels 68, etc.). In some of the examples disclosed herein, each flow channel 68 is the region defined between two sequencing surfaces (e.g., 44A and 44A' or 44B and 44B') and two attached substrates (e.g., 66A and 66A' or 66B and 66B'). In other examples disclosed herein, each flow channel 68 is the region defined between one sequencing surface (e.g., 44A or 44B) and the lid. Incorporation mixtures 10A-10F, imaging mixtures 56, 56', 56'', and other fluids described herein can be introduced into and removed from flow channel(s) 68. Each flow channel 68 may be isolated within the flow cell 64 such that fluid introduced into any particular flow channel 68 does not flow into any adjacent flow channel 68 .
[0218] A portion of the flow channel 68 may be defined in the substrate 66 using any suitable technique, depending in part on the material of the substrate 66. In one example, a portion of the flow channel 68 is etched into a glass substrate, such as substrate 66A, 66A'. In another example, a portion of the flow channel 68 may be patterned into the resin 72, 72' of the multilayer substrate 66B, 66B' using photolithography, nanoimprint lithography, or the like. A separate material (e.g., material 74 in FIGS. 8B and 8C) may be applied to the substrate 66, such that the separate material defines at least a portion of the walls of the flow channel 68.
[0219] In one example, the flow channels 68 have a substantially rectangular configuration with rounded ends. The length and width of the flow channels 68 may be less than the length and width, respectively, of the substrate 66, such that a portion of the substrate surface surrounding the flow channels 68 is available for bonding to another substrate 66 or a lid. In some cases, the width of each flow channel 68 may be at least about 1 mm, at least about 2.5 mm, at least about 5 mm, at least about 7 mm, at least about 10 mm, or more. In some cases, the length of each flow channel 68 may be at least about 10 mm, at least about 25 mm, at least about 50 mm, at least about 100 mm, or more. The width and / or length of each flow channel 68 may be greater than, less than, or somewhere in between the values specified above. In another example, the flow channels 68 are square (e.g., 10 mm x 10 mm).
[0220] The depth of each flow channel 68 may be as little as a few monolayers thick, for example, when microcontact, aerosol, or inkjet printing is used to deposit the separate material 74 defining the flow channel walls. In other examples, the depth of each flow channel 68 may be about 1 μm, about 10 μm, about 50 μm, about 100 μm, or more. In one example, the depth may range from about 10 μm to about 100 μm. In another example, the depth is about 5 μm or less. It should be understood that the depth of each flow channel 68 may also be greater than, less than, or between the values specified above. The depth of the flow channel 68 may also vary along the length and width of the flow cell 64, for example, when a patterned sequencing surface 44B, 44B′ is used.
[0221] 8B shows a cross-sectional view of a flow cell 64 including opposing unpatterned sequencing surfaces 44A, 44A'. In one example, each of these surfaces 44A, 44A' may be fabricated on a substrate 66A, 66A', which may then be bonded to one another to form an example flow cell 64. Any suitable bonding material 74, such as an adhesive, a radiation-absorbing material that aids bonding, or the like, may be used to bond the substrates 66A, 66A' together.
[0222] 8B, a portion of the flow channel 68 is defined in each of the single-layer substrates 66A, 66A'. For example, each substrate 66A, 66A' may have a recessed region 76A, 76A' defined therein into which components of the sequencing surface 44A, 44A' may be introduced. It should be understood that any space within the recessed region 76A, 76A' that is not occupied by components of the sequencing surface 44A, 44A' may be considered to be part of the flow channel 68.
[0223] The sequencing surface 44A, 44A' includes a polymer hydrogel 78A, 78A' and amplification primers 80A, 82A or 80A', 82A' bound to the polymer hydrogel 78A, 78A". Although not shown, some examples of the sequencing surface 44A, 44A' may also include a binding agent (e.g., streptavidin, avidin, biotin, etc.) capable of binding to the surface tethers 42. This binding agent may be present within the recessed regions 76A, 76A'.
[0224] Examples of polymer hydrogels 78A, 78A′ include acrylamide copolymers such as poly(N-(5-azidoacetamidylpentyl)acrylamide-co-acrylamide), PAZAM. PAZAM and some other forms of acrylamide copolymers are represented by the following structure (I):
[0225] [ka] During the ceremony, R Ais selected from the group consisting of azide, optionally substituted amino, optionally substituted alkenyl, optionally substituted alkyne, halogen, optionally substituted hydrazone, optionally substituted hydrazine, carboxyl, hydroxy, optionally substituted tetrazole, optionally substituted tetrazine, nitrile oxide, nitrone, sulfate, and thiol; R B is H or optionally substituted alkyl; R C , R D , and R E are each independently selected from the group consisting of H and optionally substituted alkyl; -(CH2) p - may be optionally replaced by p is an integer ranging from 1 to 50; n is an integer ranging from 1 to 50,000, and m is an integer ranging from 1 to 100,000).
[0226] Those skilled in the art will recognize that the arrangement of the repeating features "n" and "m" in structure (I) is representative and that the monomer subunits may be present in any order in the polymer structure (e.g., random, block, patterned, or combinations thereof).
[0227] The molecular weight of PAZAM and other forms of acrylamide copolymers can range from about 5 kDa to about 1500 kDa, or from about 10 kDa to about 1000 kDa, or in a particular example, can be about 312 kDa.
[0228] In some instances, PAZAM and other forms of acrylamide copolymers are linear polymers. In other instances, PAZAM and other forms of acrylamide copolymers are lightly crosslinked polymers.
[0229] In other examples, the polymer hydrogels 78A, 78A' may be variations of structure (I). In one example, the acrylamide units are N,N-dimethylacrylamide.
[0230] [ka] In this example, the acrylamide unit of structure (I) can be replaced by
[0231] [ka] where R D , R E , and R F are each H or C1-C6 alkyl, and R G and R H are each C1-C6 alkyl (rather than H as in acrylamide). In this example, q may be an integer ranging from 1 to 100,000. In another example, in addition to the acrylamide units, N,N-dimethylacrylamide may be used. In this example, structure (I) contains, in addition to the repeating features "n" and "m",
[0232] [ka] where R D , R E , and R F are each H or C1-C6 alkyl, and R G and R H is a C1-C6 alkyl. In this example, q can be an integer ranging from 1 to 100,000.
[0233] As another example of polymer hydrogel 78A, 78A′, the repeating “n” feature of structure (I) may be replaced with a heterocyclic azide group-containing monomer having structure (II):
[0234] [ka] In the formula, R 1is H or C1-C6 alkyl, R2 is H or C1-C6 alkyl, L is a linker comprising a linear chain having 2-20 atoms selected from the group consisting of carbon, oxygen, and nitrogen, with 10 optional substituents on the carbons and an optional nitrogen atom in the chain, E is a linear chain comprising 1-4 atoms selected from the group consisting of carbon, oxygen, and nitrogen, with optional substituents on the carbons and any nitrogen atoms in the linear chain, A is an N-substituted amide in which H or a C1-C4 alkyl is bonded to the N, and Z is a nitrogen-containing heterocycle. Examples of Z include 5- to 10-membered rings that exist as single ring structures or fused structures. Some specific examples of Z include pyrrolidinyl, pyridinyl, or pyrimidinyl.
[0235] As yet another example, polymer hydrogels 78A, 78A′ may include repeating units of structures (III) and (IV), respectively:
[0236] [ka] where R 1a , R 2a , R 1b and R 2b each independently selected from hydrogen, optionally substituted alkyl, or optionally substituted phenyl; R 3a and R 3b each is independently selected from hydrogen, optionally substituted alkyl, optionally substituted phenyl, or optionally substituted C7-C14 aralkyl; 1 and L 2 are independently selected from an optionally substituted alkylene linker or an optionally substituted heteroalkylene linker.
[0237] It should be understood that other monomers can be used to form the polymer hydrogels 78A, 78A', as long as they are functionalized to graft the amplification primers 80A, 82A, or 80A', 82A'. Other examples of suitable polymer layers include colloidal structures such as agarose, or polymer mesh structures such as gelatin, or cross-linked polymer structures such as polyacrylamide polymers and copolymers, silane-free acrylamide (SFA), or azide-decomposed versions of SFA. Examples of suitable polyacrylamide polymers can be synthesized from acrylamide and acrylic acid or vinyl-containing acrylic acid, or from monomers that form a [2 + 2] photocycloaddition reaction. Still other examples of suitable polymer hydrogels 78A, 78A' include mixed copolymers of acrylamide and acrylate. Various polymer structures containing acrylic monomers (e.g., acrylamide, acrylate, etc.) can be utilized in the embodiments disclosed herein, including star polymers, star-shaped or star-block polymers, branched polymers including dendrimers, etc. For example, monomers (such as acrylamide) can be incorporated into the branches (arms) of a star polymer, either randomly or in blocks.
[0238] To introduce the polymer hydrogel 78A, 78A' into the recessed regions 76A, 76A', a mixture of the polymer hydrogel 78A, 78A' can be formed and then applied to the respective substrates 66A, 66A' (having recessed regions 76A, 76A' defined therein). In one example, the polymer hydrogel 78A, 78A' can be present in a mixture (e.g., with water, or with ethanol and water). The mixture can then be applied to the respective substrate surfaces (including the recessed regions 76A, 76A') using spin coating, dipping or dip coating, flow of material under positive or negative pressure, or another suitable technique. These types of techniques indiscriminately deposit the polymer hydrogel 78A, 78A' on the respective substrate surfaces 66A, 66A' (e.g., within the recessed regions 76A, 76A' and on the adjacent interstitial regions 84A, 84A'). Other selective deposition techniques (including, for example, masks, controlled printing techniques, etc.) can be used to specifically deposit the polymer hydrogel 78A, 78A' in the recessed regions 76A, 76A' but not in the gap regions 84A, 84A'.
[0239] In some examples, the substrate surface (including recessed regions 76A, 76A') can be activated, and then the mixture (including polymer hydrogel 78A, 78A') can be applied thereto. In one example, a silane or silane derivative (e.g., norbornene silane) can be deposited on the substrate surface using vapor deposition, spin coating, or other deposition methods. In another example, the substrate surface can be exposed to plasma ashing to produce surface-activating agents (e.g., -OH groups) that can attach to the polymer hydrogel 78A, 78A'.
[0240] Depending on the chemical nature of the polymer hydrogel 78A, 78A', the applied mixture may be subjected to a curing process. In one example, curing may occur at temperatures ranging from room temperature (e.g., about 25°C) to about 95°C for times ranging from about 1 millisecond to about several days.
[0241] Polishing can then be performed to remove the polymer hydrogel 78A, 78A' from the gap regions 84A, 84A' surrounding the recessed regions 76A, 76A', while leaving the polymer hydrogel 78A, 78A' on the surfaces of the recessed regions 76A, 76A' at least substantially intact.
[0242] The sequencing surface 44A, 44A' also includes amplification primers 80A, 82A or 80A', 82A' bound to a polymer hydrogel 78A, 78A'.
[0243] A grafting process can be performed to graft the amplification primers 80A, 82A, or 80A', 82A' to the polymer hydrogel 78A, 78A' within the recessed regions 76A, 76A'. In one example, the amplification primers 80A, 82A, or 80A', 82A' can be immobilized to the polymer hydrogel 78A, 78A' by a single-point covalent bond at or near the 5' end of the primers 80A, 82A, or 80A', 82A'. This bond allows i) the adapter-specific portion of the primers 80A, 82A, or 80A', 82A' to freely anneal to their cognate sequenceable nucleic acid fragments, and ii) the 3' hydroxyl group to freely extend the primer. Any suitable covalent bond can be used for this purpose. Examples of terminal primers that can be used include alkyne-terminated primers (e.g., that can bind to azide surface moieties of polymer hydrogels 78A, 78A') or azide-terminated primers (e.g., that can bind to alkyne surface moieties of polymer hydrogels 78A, 78A').
[0244] Specific examples of suitable primers 80A, 82A or 80A', 82A' include the P5 and P7 primers used on the surface of commercially available flow cells sold by Illumina Inc. for sequencing on HISEQ™, HISEQX™, MISEQ™, MISEQDX™, MINISEQ™, NEXTSEQ™, NEXTSEQDX™, NOVASEQ™, GENOME ANALYZER™, ISEQ™, and other instrument platforms. Either of the P5 and P7 primers can be grafted onto polymer hydrogels 78A, 78A', respectively.
[0245] In one example, grafting can be by flow-through deposition (e.g., using a temporarily attached lid), dunk coating, spray coating, droplet dispensing, or another suitable method of attaching the primer(s) 80A, 82A, or 80A', 82A' to the polymer hydrogel 78A, 78A'. Each of these exemplary techniques can utilize a primer solution or mixture that can include the primer(s) 80A, 82A, or 80A', 82A', water, a buffer, and a catalyst. Using any of the grafting methods, the primer 42, 42' reacts with the reactive groups of the polymer hydrogel 78A, 78A' in the recessed regions 76A, 76A' and has no affinity for the surrounding substrate 66A, 66A'. Thus, the primer 80A, 82A, or 80A', 82A' selectively implants into the polymer hydrogel 78A, 78A'.
[0246] 8C shows a cross-sectional view of a flow cell 64 including patterned opposing sequencing surfaces 44B, 44B'. In one example, each of these surfaces 44B, 44B' may be fabricated on a substrate 66B, 66B', which may then be bonded to one another (e.g., via material 74) to form the example flow cell 64.
[0247] 8C, flow cell 64 includes multi-layer substrates 66B, 66B', each of which includes a support 70, 70' and a patterned material 72, 72' disposed on the support 70, 70'. The patterned material 72, 72' defines recesses 88, 88' separated by gap regions 84B, 84B'.
[0248] 8C, patterned materials 72, 72′ are disposed on supports 70, 70′, respectively. It should be understood that any material that can be selectively deposited, or deposited and patterned, to form recesses 88, 88′ and gap regions 84B, 84B′ can be used for patterned materials 72, 72′.
[0249] As an example, inorganic oxides may be selectively applied to the substrates 70, 70' via vapor deposition, aerosol printing, or inkjet printing. Examples of suitable inorganic oxides include tantalum oxide (e.g., TaO), aluminum oxide (e.g., AlO), silicon oxide (e.g., SiO), hafnium oxide (e.g., HfO), and the like.
[0250] As another example, the resin can be applied to the substrate 70, 70′ and then patterned. Suitable deposition techniques include chemical vapor deposition, dip coating, dunk coating, spin coating, spray coating, droplet dispensing, ultrasonic spray coating, doctor blade coating, aerosol printing, screen printing, microcontact printing, and the like. Suitable patterning techniques include photolithography, nanoimprint lithography (NIL), stamping techniques, embossing techniques, molding techniques, microetching techniques, printing techniques, and the like. Some examples of suitable resins include polyhedral oligomeric silsesquioxane-based resins, non-polyhedral oligomeric silsesquioxane epoxy resins, poly(ethylene glycol) resins, polyether resins (e.g., ring-opened epoxies), acrylic resins, acrylate resins, methacrylate resins, amorphous fluoropolymer resins (e.g., CYTOP® from Bellex), and combinations thereof.
[0251] As used herein, the term "polyhedral oligomeric silsesquioxane" (commercially available from Hybrid Plastics under the trade name "POSS") refers to a hybrid intermediate between silica (SiO) and silicon (RSiO) (e.g., RSiO 1.5 ) refers to a chemical composition having the formula [RSiO 3 / 2 ] nThe R groups may be the same or different. Exemplary R groups in POSS include epoxy, azide / azido, thiol, poly(ethylene glycol), norbornene, tetrazine, acrylate, and / or methacrylate, or even alkyl, aryl, alkoxy, and / or haloalkyl groups, for example. The resin compositions disclosed herein may contain one or more different cage or core structures as monomer units. The average cage content may be adjusted during synthesis and / or controlled by purification methods, and a distribution of cage sizes of the monomer units may be used in the embodiments disclosed herein.
[0252] As shown in FIG. 8C , the patterned material 72, 72′ includes depressions 88, 88′ defined therein, respectively, and gap regions 84B, 84B′ separating adjacent depressions 88, 88′. Many different layouts of the depressions 88, 88′ can be envisioned, including regular, repeating, and irregular patterns. In one example, the depressions 88, 88′ are arranged in a hexagonal grid for close packing and improved density. Other layouts can include, for example, rectilinear (rectangular) layouts, triangular layouts, etc. In some examples, the layout or pattern can be an xy format of depressions 88, 88′ in rows and columns. In other examples, the layout or pattern can be a repeating arrangement of depressions 88, 88′ and / or gap regions 84B, 84B′. In yet other examples, the layout or pattern can be a random arrangement of depressions 88, 88′ and / or gap regions 84B, 84B′. The patterns may include stripes, swirls, lines, triangles, rectangles, circles, arcs, checkerboards, diagonals, arrows, and / or squares.
[0253] The layout or pattern of the dimples 88, 88' may be characterized by the density of the dimples 88, 88' (e.g., the number of dimples 88, 88') in a defined area. For example, the dimples 88, 88' may be spaced apart from each other by 1 mm. 2 They can be present at a density of about 2 million per mm. 2Approximately 100 per 1mm 2 Approximately 1,000 per 1mm 2 Approximately 100,000 per mm 2 Approximately 1 million per mm 2 Approximately 2 million per 1mm 2 Approximately 5 million per mm 2 Approximately 10 million per mm 2 The density of the depressions 88, 88' in the patterned material 72, 72' can be adjusted to different densities, including densities of about 50 million per depression, or less. It should be further understood that the density of the depressions 88, 88' in the patterned material 72, 72' can be between one of the lower values and one of the upper values selected from the ranges above. By way of example, a high-density array can be characterized as having depressions 88, 88' separated by less than about 100 nm, a medium-density array can be characterized as having depressions 88, 88' separated by about 400 nm to about 1 μm, and a low-density array can be characterized as having depressions 88, 88' separated by more than about 1 μm. While example densities are provided, it should be understood that any suitable density can be used. The density of the depressions 88, 88' can depend in part on the depth of the depressions 88, 88'. In some cases, it may be desirable for the spacing between the depressions 88, 88' to be even greater than the examples listed herein.
[0254] The layout or pattern of the depressions 88, 88′ may also, or alternatively, be characterized in terms of average pitch, or the spacing from the center of one depression 88, 88′ to the center of an adjacent depression 88, 88′ (center-to-center spacing), or the spacing from the left edge of one depression 88, 88′ to the right edge of the adjacent depression 88, 88′ (edge-to-edge spacing). The pattern may be regular so that the coefficient of variation around the average pitch is small, or the pattern may be irregular, in which case the coefficient of variation may be relatively large. In either case, the average pitch may be, for example, approximately about 50 nm, about 0.1 μm, about 0.5 μm, about 1 μm, about 5 μm, about 10 μm, or about 100 μm. The average pitch of a particular pattern of depressions 88, 88′ may be between one of the lower and upper values selected from the ranges above. In one example, the depressions 88, 88' have a pitch (center-to-center spacing) of about 1.5 μm. Although example average pitch values are provided, it should be understood that other average pitch values may also be used.
[0255] The size of each of the recesses 88, 88' may be characterized by its volume, open area, depth, and / or diameter.
[0256] Each of the recesses 88, 88′ may have any volume capable of confining at least some of the fluid introduced into the flow cell 64. The minimum or maximum volume may be selected to correspond, for example, to the throughput (e.g., multiplexing), resolution, nucleotide, or analyte reactivity expected for downstream use of the flow cell 64. For example, the volume may be at least about 1×10 -3 μm 3 , at least about 1 x 10 -2 μm 3 , at least about 0.1 μm 3 , at least about 1 μm 3 , at least about 10 μm 3 , at least about 100 μm 3 Alternatively or additionally, the volume may be at most about 1×10 4 μm 3 , up to about 1 × 10 3μm 3 , up to about 100 μm 3 , up to about 10 μm 3 , up to about 1 μm 3 , up to about 0.1 μm 3 , or even less.
[0257] The area occupied by each recess opening can be selected based on the same criteria as the volume described above. For example, the area of each recess opening is at least about 1×10 -3 μm 2 , at least about 1 x 10 -2 μm 2 , at least about 0.1 μm 2 , at least about 1 μm 2 , at least about 10 μm 2 , at least about 100 μm 2 Alternatively or additionally, the area may be at most about 1×10 3 μm 2 , up to about 100 μm 2 , up to about 10 μm 2 , up to about 1 μm 2 , up to about 0.1 μm 2 , up to about 1 × 10 -2 μm 2 The area occupied by the opening of each recess may be greater than, less than, or in between the above values.
[0258] The depth of each depression 88, 88' can be large enough to accommodate a portion of the polymer hydrogel 78B, 78B'. In one example, the depth can be at least about 0.1 μm, at least about 0.5 μm, at least about 1 μm, at least about 10 μm, at least about 100 μm, or more. Alternatively or additionally, the depth can be at most about 1×10 3 The depth may be up to about 100 μm, up to about 10 μm, or less. In some examples, the depth is about 0.4 μm. The depth of each depression 88, 88′ may be greater than, less than, or between the values recited above.
[0259] In some examples, the diameter or length and width of each of the depressions 88, 88' can be at least about 50 nm, at least about 0.1 μm, at least about 0.5 μm, at least about 1 μm, at least about 10 μm, at least about 100 μm, or more. Alternatively or additionally, the diameter or length and width can be at most about 1×10 3 The diameter or length and width of each depression 88, 88' may be greater than, less than, or between the above values.
[0260] In this example, at least some of the components of sequencing surface 44B, 44B' may be introduced into recesses 88, 88'. It should be understood that any space within recesses 88, 88' that is not occupied by components of sequencing surface 44B, 44B' may be considered to be part of flow channel 68.
[0261] In the example shown in Figure 8C, a polymer hydrogel 78B, 78B' is disposed within each of the depressions 88, 88'. The polymer hydrogel 78B, 78B' may be any of the examples described herein for the polymer hydrogel 78A, 78A' and may be applied (e.g., deposited and subsequently polished) as described with reference to Figure 8B, so that the polymer hydrogel 78B, 78B' is present within the depressions 88, 88' and not over the surrounding void regions 84B, 84B'.
[0262] In the example shown in Figure 8C, primers 80B, 82B or 80B', 82B' may be any of the examples described herein for primers 80A, 82A or 80A', 82A' and may be grafted to polymer hydrogels 78B, 78B' within recesses 88, 88', respectively. Primers 80B, 82B or 80B', 82B' may be applied as described with reference to Figure 8B, thus grafting to polymer hydrogels 78B, 78B' and not to the surrounding interstitial regions 84B, 84B'.
[0263] Although not shown, some examples of sequencing surfaces 44B, 44B' can also include a binding agent (e.g., streptavidin, avidin, biotin, etc.) that can bind to surface tethers 42. This binding agent can be present in recesses 88, 88'.
[0264] As shown in Figures 8B and 8C, substrates 66A and 66A' or 66B and 66B' are bonded to one another such that sequencing surfaces 44A and 44A' or 44B and 44B' face each other with a flow channel 68 defined therebetween.
[0265] Substrates 66A and 66A' or 66B and 66B' may be bonded to one another in some or all of gap regions 84A and 84A' or 84B and 84B'. The bond formed between substrates 66A and 66A' or 66B and 66B' can be a chemical bond or a mechanical bond (e.g., using fasteners, etc.).
[0266] Any suitable technique may be used to bond substrates 66A and 66A' or 66B and 66B' together, such as laser bonding, diffusion bonding, anodic bonding, eutectic bonding, plasma activated bonding, glass frit bonding, or other methods known in the art. In one example, a spacer layer (e.g., material 74) may be used to bond substrates 66A and 66A' or 66B and 66B'. The spacer layer may be any material 74 that seals at least a portion of substrates 66A and 66A' or 66B and 66B' together. In some examples, the spacer layer may be a radiation absorbing material that aids in bonding.
[0267] Although not shown, it is understood that a lid may be attached to one of substrates 66A or 66B such that the flow cell has one sequencing surface.
[0268] Additional Notes It should be understood that all combinations of the foregoing concepts and additional concepts discussed in more detail below (unless such concepts are mutually inconsistent) are contemplated as being part of the inventive subject matter disclosed herein. Specifically, all combinations of claimed subject matter appearing at the end of this disclosure are contemplated as being part of the inventive subject matter disclosed herein. It should also be understood that terms used expressly herein, and which may also appear in any disclosures incorporated by reference, should be given the meaning most consistent with the particular concepts disclosed herein.
[0269] References throughout this specification to "one example," "another example," "an example," etc. mean that a particular element (e.g., a feature, structure, and / or characteristic) described in connection with an example is included in at least one example described herein and may or may not be present in other examples. Furthermore, unless the context clearly dictates otherwise, it should be understood that the described elements with respect to any example may be combined in any suitable manner in the various examples.
[0270] Ranges provided herein should be understood to include the stated range and any value or subrange within that stated range, as if such value or subrange were expressly recited. For example, a range of about 2 mm to about 300 mm should be interpreted to include not only the explicitly recited limits of about 2 mm to about 300 mm, but also individual values such as about 40 mm, about 250.5 mm, etc., and subranges such as about 25 mm to about 175 mm.
[0271] Additionally, when "about" and / or "substantially" are used to describe values, they are meant to encompass small variations (up to ±10%) from the stated value.
[0272] Although several embodiments have been described in detail, it should be understood that the disclosed examples may be modified, and therefore the foregoing description should be considered non-limiting.
[0273] Typical features Representative features are described in the following numbered clauses and may be used alone or in any combination with one or more features disclosed in the text and / or drawings of this specification. Clause 1. Incorporated mixtures, a liquid carrier; A complex, polymerase, and a complex comprising a plasmonic nanostructure linked to a polymerase; A labeled nucleotide, nucleotide, a 3'OH blocking group attached to the sugar of the nucleotide, and a labeled nucleotide comprising a dye label attached to a base of the nucleotide; An incorporation mixture comprising: Clause 2. The incorporation mixture of clause 1, wherein the plasmonic nanostructures are selected from the group consisting of gold nanostructures, silver nanostructures, tin nanostructures, rhodium nanostructures, ruthenium nanostructures, palladium nanostructures, osmium nanostructures, iridium nanostructures, platinum nanostructures, chromium nanostructures, copper nanostructures, gallium arsenide nanostructures, doped silicon nanostructures, aluminum nanostructures, magnesium nanostructures, silver and gold composite nanostructures, and combinations thereof. Clause 3. The incorporation mixture of clause 1 or clause 2, wherein the plasmonic nanostructures are chemically conjugated to amines or cysteines of the polymerase. Article 4. an oligonucleotide bound to a polymerase; 4. The incorporation mixture of any one of clauses 1 to 3, wherein the oligonucleotides hybridize to complementary oligonucleotide tethers attached to the plasmonic nanostructure. Article 5. an oligonucleotide bound to a polymerase; 5. The incorporation mixture of clauses 1-4, wherein the oligonucleotide hybridizes to a complementary portion of an oligonucleotide tether that also includes an additional portion wrapped around the plasmonic nanostructure. Article 6. the plasmonic nanostructure is functionalized with a first member of a binding pair; 6. The incorporation mixture of clauses 1-5, wherein the polymerase comprises or is functionalized with a second member of the binding pair. Clause 7. The incorporation mixture of clause 6, wherein the first member and the second member comprise a NiNTA ligand and a histidine tag, or streptavidin and biotin, or a spy tag and a spy catcher, or a maleimide and a cysteine, or an azide and a dibenzocyclooctyne. Clause 8. A method comprising: introducing an incorporation mixture into a flow cell containing clusters of template strands, the incorporation mixture comprising: a liquid carrier; A plurality of conjugates, each conjugate comprising: polymerase, and a plurality of complexes comprising a plasmonic nanostructure linked to a polymerase; a plurality of labeled nucleotides, each labeled nucleotide comprising: nucleotide, a 3'OH blocking group attached to the sugar of the nucleotide, and a plurality of labeled nucleotides comprising dye labels attached to the bases of the nucleotides; introducing an incorporation mixture whereby at least one polymerase i) incorporates each one of the labeled nucleotides into the nascent strand along one of the template strands and ii) maintains its linked plasmonic nanostructure within proximity of each one of the labeled nucleotides; optically imaging the integration while the plasmonic nanostructures are maintained; A method comprising: Clause 9. Kits comprising: 1. An integrated mixture comprising: a liquid carrier; A polymerase and A labeled nucleotide, nucleotide, a 3'OH blocking group attached to the sugar of the nucleotide, and a labeled nucleotide comprising a dye label attached to a base of the nucleotide; and 1. An imaging mixture comprising: a second liquid carrier; an imaging mixture comprising: a plasmonic nanostructure functionalized to associate with itself within the proximity of the labeled nucleotide after an incorporation event involving the labeled nucleotide; A kit comprising an integration mixture comprising: Clause 10. The kit of clause 9, wherein the plasmonic nanostructures are selected from the group consisting of gold nanostructures, silver nanostructures, tin nanostructures, rhodium nanostructures, ruthenium nanostructures, palladium nanostructures, osmium nanostructures, iridium nanostructures, platinum nanostructures, chromium nanostructures, copper nanostructures, gallium arsenide nanostructures, doped silicon nanostructures, aluminum nanostructures, magnesium nanostructures, silver and gold composite nanostructures, and combinations thereof. Clause 11. The kit of clause 9 or clause 10, wherein the plasmonic nanostructure is functionalized with a second polymerase. Clause 12. The kit of clause 11, wherein the plasmonic nanostructure is chemically conjugated to an amine or cysteine of the second polymerase. Article 13. The oligonucleotide binds to a second polymerase; 12. The kit of clause 11, wherein the oligonucleotide hybridizes to a complementary oligonucleotide tether attached to the plasmonic nanostructure. Article 14. The oligonucleotide binds to a second polymerase; 12. The kit of clause 11, wherein the oligonucleotide is hybridized to a complementary oligonucleotide tether that includes a portion wrapped around the plasmonic nanostructure. Article 15. the plasmonic nanostructure is functionalized with a first member of a binding pair; 15. The kit of clauses 9 to 14, wherein the polymerase comprises or is functionalized with a second member of the binding pair. Clause 16. The kit of clause 15, wherein the first member and the second member comprise a NiNTA ligand and a histidine tag, or streptavidin and biotin, or a spy tag and a spy catcher, or a maleimide and a cysteine, or an azide and a dibenzocyclooctyne. Clause 17. The kit of clause 15 or clause 16, wherein the polymerase further comprises a DNA binding domain bound to its surface. Clause 18. The polymerase a surface tether attached to the surface; 18. The kit of any one of clauses 15 to 17, further comprising a flow cell surface binding agent attached to the surface tether. Article 19. The plasmonic nanostructures are functionalized with streptavidin, 19. The kit of any one of clauses 9 to 18, wherein the labeled nucleotide is biotinylated. Clause 20. A method comprising: introducing an incorporation mixture into a flow cell containing clusters of template strands, the incorporation mixture comprising: a liquid carrier; Multiple polymerases; a plurality of labeled nucleotides, each labeled nucleotide comprising: nucleotide, a 3'OH blocking group attached to the sugar of the nucleotide, and a plurality of labeled nucleotides comprising dye labels attached to the bases of the nucleotides; Including, introducing an incorporation mixture whereby at least one polymerase incorporates individual ones of the labeled nucleotides into a nascent strand along one of the template strands; introducing an imaging mixture into the flow cell, the imaging mixture comprising: a second liquid carrier; a plurality of functionalized plasmonic nanostructures; introducing an imaging mixture whereby at least one of the functionalized plasmonic nanostructures associates itself within proximity of each of the labeled nucleotides; optically imaging the incorporation while at least one of the functionalized plasmonic nanostructures is associated with each of the labeled nucleotides; A method comprising: Clause 21. A method according to clause 20, comprising: each of the functionalized plasmonic nanostructures is functionalized with a second polymerase; 21. The method of clause 20, wherein the method further comprises removing the incorporation mixture prior to introducing the imaging mixture. Clause 22. A method according to clause 20 or 21, comprising: each of the functionalized plasmonic nanostructures is functionalized with a first member of a binding pair; each of the polymerases comprises a second member of a binding pair; 22. The method of clause 20 or 21, wherein the method further comprises removing the incorporation mixture prior to introducing the imaging mixture. Clause 23. A method according to any one of clauses 21 or 22, comprising: each of the functionalized plasmonic nanostructures is functionalized with streptavidin; Each of the labeled nucleotides is biotinylated, 23. The method of clause 21 or 22, wherein the method further comprises removing the incorporation mixture prior to introducing the imaging mixture. Clause 24. A labeled nucleotide, A nucleotide, a 3'OH blocking group attached to the sugar of the nucleotide; a dye label attached to the base of the nucleotide; a plasmonic nanostructure attached to a base or a dye label of the nucleotide. Clause 25. The labeled nucleotide of clause 24, wherein the plasmonic nanostructure is selected from the group consisting of gold nanostructures, silver nanostructures, tin nanostructures, rhodium nanostructures, ruthenium nanostructures, palladium nanostructures, osmium nanostructures, iridium nanostructures, platinum nanostructures, chromium nanostructures, copper nanostructures, gallium arsenide nanostructures, doped silicon nanostructures, aluminum nanostructures, magnesium nanostructures, silver and gold composite nanostructures, and combinations thereof. Clause 26. The labeled nucleotide of clause 24 or 25, wherein the plasmonic nanostructure is attached to the base of the nucleotide via a double-stranded deoxyribonucleic acid chain. Article 27. a first linking molecule attaching a dye label to the base of the nucleotide; a second linking molecule attaches the plasmonic nanostructure to the base of the nucleotide; 27. The labeled nucleotide of any one of clauses 24 to 26, wherein the first linking molecule has a first length within about 3 nm to about 12 nm of the second length of the second linking molecule. Article 28. a first linking molecule attaching a dye label to the base of the nucleotide; a second linking molecule attaches the plasmonic nanostructure to the base of the nucleotide; 28. The labeled nucleotide of any one of clauses 24 to 27, wherein the first linking molecule has a first length and the second linking molecule has a second length, and the first and second lengths are in the range of about 3 nm to about 12 nm. Clause 29. A method comprising: introducing an incorporation mixture into a flow cell containing clusters of template strands, the incorporation mixture comprising: a liquid carrier; Multiple polymerases; a plurality of labeled nucleotides, each labeled nucleotide comprising: nucleotide, a 3'OH blocking group attached to the sugar of the nucleotide, a dye label attached to the base of the nucleotide, and introducing the incorporation mixture into a flow cell containing a cluster of template strands, the cluster comprising a plurality of labeled nucleotides, the plurality of labeled nucleotides comprising plasmonic nanostructures bound to the bases of the nucleotides; whereby at least one polymerase incorporates each one of the labeled nucleotides into a nascent strand along one of the template strands; and optically imaging the integration.
Claims
1. An integration mixture comprising: A liquid carrier; A complex comprising: Polymerase, and a complex comprising a plasmonic nanostructure linked to the polymerase; A labeled nucleotide, nucleotide, a 3' OH blocking group attached to the sugar of the nucleotide; and and a labeled nucleotide comprising a dye label attached to a base of the nucleotide.
2. 2. The incorporation mixture of claim 1, wherein the plasmonic nanostructures are chemically conjugated to amines or cysteines of the polymerase.
3. an oligonucleotide is bound to said polymerase; i) the oligonucleotide hybridizes to a complementary oligonucleotide tether attached to the plasmonic nanostructure; or ii) the oligonucleotide hybridizes to a complementary portion of an oligonucleotide tether that also includes an additional portion wrapped around the plasmonic nanostructure.
4. A kit comprising: An integration mixture comprising: A liquid carrier; A polymerase, A labeled nucleotide, nucleotide, a 3' OH blocking group attached to the sugar of the nucleotide; and a labeled nucleotide comprising a dye label attached to a base of the nucleotide; and 1. An imaging mixture comprising: a second liquid carrier; a plasmonic nanostructure functionalized to associate with itself within the vicinity of the labeled nucleotide following an incorporation event involving the labeled nucleotide; Kit including:
5. The plasmonic nanostructure is functionalized with a second polymerase, and optionally The kit of claim 4 , wherein the plasmonic nanostructures are chemically conjugated to amines or cysteines of the second polymerase.
6. an oligonucleotide binds to the second polymerase; i) the oligonucleotide hybridizes to a complementary oligonucleotide tether attached to the plasmonic nanostructure, or 6. The kit of claim 4 or 5, wherein ii) the oligonucleotide hybridizes to a complementary oligonucleotide tether that comprises a portion that is wrapped around the plasmonic nanostructure.
7. the plasmonic nanostructure is functionalized with a first member of a binding pair; An incorporation mixture according to any of claims 1 to 3 or a kit according to any of claims 4 to 6, wherein the polymerase comprises or is functionalised with a second member of the binding pair, and optionally the first and second members comprise a NiNTA ligand and a histidine tag, or streptavidin and biotin, or a Spitag and a Spicatcher, or a maleimide and a cysteine, or an azide and a dibenzocyclooctyne.
8. 8. The kit of any of claims 4 to 7, wherein the polymerase further comprises i) a DNA binding domain bound to its surface, or ii) a surface tether bound to its surface, and a flow cell surface binding agent bound to the surface tether.
9. the plasmonic nanostructures are functionalized with streptavidin; The kit according to any one of claims 4 to 8, wherein the labeled nucleotide is biotinylated.
10. 1. A method comprising: Introducing an incorporation mixture into a flow cell containing clusters of template strands, said incorporation mixture comprising: A liquid carrier; A plurality of polymerases; A plurality of labeled nucleotides, each labeled nucleotide comprising: nucleotide, a 3' OH blocking group attached to the sugar of the nucleotide; and a plurality of labeled nucleotides comprising dye labels attached to bases of the nucleotides; introducing an incorporation mixture whereby at least one of the polymerases incorporates individual ones of the labeled nucleotides into a nascent strand along one of the template strands; Introducing an imaging mixture into the flow cell, the imaging mixture comprising: a second liquid carrier; a plurality of functionalized plasmonic nanostructures; introducing an imaging mixture whereby at least one of the functionalized plasmonic nanostructures associates itself within proximity of a respective one of the labeled nucleotides; optically imaging the incorporation while at least one of the functionalized plasmonic nanostructures is associated with a respective one of the labeled nucleotides; A method comprising:
11. each of said functionalized plasmonic nanostructures is functionalized with i) a second polymerase, or ii) a first member of a binding pair, or iii) streptavidin; each of said polymerases comprises a second member of said binding pair; each of the labeled nucleotides is biotinylated; The method of claim 10 , wherein the method further comprises removing the incorporation mixture prior to introducing the imaging mixture.
12. A labeled nucleotide, A nucleotide, a 3' OH blocking group attached to the sugar of the nucleotide; a dye label attached to a base of the nucleotide; a plasmonic nanostructure attached to a base of the nucleotide or to the dye label; Optionally, the plasmonic nanostructure is attached to a base of the nucleotide via a double-stranded deoxyribonucleic acid strand.
13. a first linking molecule attaches the dye label to a base of the nucleotide; a second linking molecule attaches the plasmonic nanostructure to a base of the nucleotide; i) the first linking molecule has a first length within about 3 nm to about 12 nm of a second length of the second linking molecule; or ii) the first linked molecule has a first length and the second linked molecule has a second length, the first and second lengths combined being in the range of about 3 nm to about 12 nm.
14. The incorporation mixture of any one of claims 1 to 3 or 7, the kit of any one of claims 4 to 9, the method of claim 10 or 11, or the labeled nucleotide of claim 12 or 13, wherein the plasmonic nanostructures are selected from the group consisting of gold nanostructures, silver nanostructures, tin nanostructures, rhodium nanostructures, ruthenium nanostructures, palladium nanostructures, osmium nanostructures, iridium nanostructures, platinum nanostructures, chromium nanostructures, copper nanostructures, gallium arsenide nanostructures, doped silicon nanostructures, aluminum nanostructures, magnesium nanostructures, silver and gold composite nanostructures, and combinations thereof.
15. 1. A method comprising: Introducing an incorporation mixture into a flow cell containing clusters of template strands, said incorporation mixture comprising: A liquid carrier; A plurality of polymerases; A plurality of labeled nucleotides, each labeled nucleotide comprising: nucleotide, a 3' OH blocking group attached to the sugar of the nucleotide; a dye label attached to a base of the nucleotide; and a plurality of labeled nucleotides comprising plasmonic nanostructures attached to bases of the nucleotides; introducing an incorporation mixture whereby at least one polymerase incorporates individual ones of the labeled nucleotides into a nascent strand along one of the template strands; and optically imaging the integration.
